[go: up one dir, main page]

Next Issue
Volume 18, September
Previous Issue
Volume 18, July
 
 
ijms-logo

Journal Browser

Journal Browser

Int. J. Mol. Sci., Volume 18, Issue 8 (August 2017) – 223 articles

Cover Story (view full-size image): During infection, the influenza A virus must engage with the host cellular protein interaction network to hijack host molecular machinery in order to fulfill the viral life cycle and perturb host defense to evade immune surveillance. On the other hand, the interaction elicits various host responses to eliminate the virus. Thus, the protein interactions between influenza A virus and host determine the outcome of viral pathogenesis. View this paper
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Section
Select all
Export citation of selected articles as:
2479 KiB  
Article
Circadian and Light Regulated Expression of CBFs and their Upstream Signalling Genes in Barley
by Krisztián Gierczik, Aliz Novák, Mohamed Ahres, András Székely, Alexandra Soltész, Ákos Boldizsár, Zsolt Gulyás, Balázs Kalapos, István Monostori, László Kozma-Bognár, Gábor Galiba and Attila Vágújfalvi
Int. J. Mol. Sci. 2017, 18(8), 1828; https://doi.org/10.3390/ijms18081828 - 22 Aug 2017
Cited by 23 | Viewed by 5695
Abstract
CBF (C-repeat binding factor) transcription factors show high expression levels in response to cold; moreover, they play a key regulatory role in cold acclimation processes. Recently, however, more and more information has led to the conclusion that, apart from cold, light—including its spectra—also [...] Read more.
CBF (C-repeat binding factor) transcription factors show high expression levels in response to cold; moreover, they play a key regulatory role in cold acclimation processes. Recently, however, more and more information has led to the conclusion that, apart from cold, light—including its spectra—also has a crucial role in regulating CBF expression. Earlier, studies established that the expression patterns of some of these regulatory genes follow circadian rhythms. To understand more of this complex acclimation process, we studied the expression patterns of the signal transducing pathways, including signal perception, the circadian clock and phospholipid signalling pathways, upstream of the CBF gene regulatory hub. To exclude the confounding effect of cold, experiments were carried out at 22 °C. Our results show that the expression of genes implicated in the phospholipid signalling pathway follow a circadian rhythm. We demonstrated that, from among the tested CBF genes expressed in Hordeum vulgare (Hv) under our conditions, only the members of the HvCBF4-phylogenetic subgroup showed a circadian pattern. We found that the HvCBF4-subgroup genes were expressed late in the afternoon or early in the night. We also determined the expression changes under supplemental far-red illumination and established that the transcript accumulation had appeared four hours earlier and more intensely in several cases. Based on our results, we propose a model to illustrate the effect of the circadian clock and the quality of the light on the elements of signalling pathways upstream of the HvCBFs, thus integrating the complex regulation of the early cellular responses, which finally lead to an elevated abiotic stress tolerance. Full article
(This article belongs to the Special Issue Abiotic Stress and Gene Networks in Plants 2017)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The expression patterns of the <span class="html-italic">HvCCA1</span> and <span class="html-italic">HvTOC1</span> (<b>A</b>,<b>B</b>) with white light and low R/FR illumination. In the first two days, the plants were illuminated for 12 h, whereas, in the next two days, they were kept under constant light conditions. Samples were collected every 4 h during four days. Transcript levels were calculated with the Δ<span class="html-italic">C</span><sub>t</sub> method. The values on the X-axes show the time in hours after dawn. The white and black bars symbolise the light and dark periods, while grey bars indicate subjective night. The data and error bars, which represent the standard deviation, originated from three technical replicates.</p>
Full article ">Figure 2
<p>The expression patterns of <span class="html-italic">HvPITP</span> and <span class="html-italic">HvPI4K</span> genes (<b>A</b>,<b>B</b>) with white light and low R/FR illumination. Conditions are the same as in <a href="#ijms-18-01828-f001" class="html-fig">Figure 1</a>.</p>
Full article ">Figure 3
<p>The expression patterns of the <span class="html-italic">HvPLD (put.)</span>, <span class="html-italic">HvCBL2</span>, <span class="html-italic">HvCaM.2</span>, <span class="html-italic">HvCDPK12</span> (<b>A</b>–<b>D</b>) with white light and low R/FR illumination. Conditions are the same as in <a href="#ijms-18-01828-f001" class="html-fig">Figure 1</a>.</p>
Full article ">Figure 4
<p>Gene expression patterns of the <span class="html-italic">HvCBF3</span> and <span class="html-italic">HvCBF6</span> (<b>A</b>,<b>B</b>) with white light and low R/FR ratio in the spectra. Conditions are the same as in <a href="#ijms-18-01828-f001" class="html-fig">Figure 1</a>.</p>
Full article ">Figure 5
<p>Gene expression levels in <span class="html-italic">HvCBF2A</span>, <span class="html-italic">HvCBF4B</span>, <span class="html-italic">HvCBF9</span> and <span class="html-italic">HvCBF14</span> (<b>A</b>–<b>D</b>) with white light and low R/FR illumination. Conditions are the same as in <a href="#ijms-18-01828-f001" class="html-fig">Figure 1</a>.</p>
Full article ">Figure 6
<p>Graphical summary of our results based on the gene expression analyses. The abbreviations (R/FR, <span class="html-italic">CCA1</span>, <span class="html-italic">LHY</span>, <span class="html-italic">PITP</span>, <span class="html-italic">PI4K</span>, <span class="html-italic">PLC</span>, <span class="html-italic">CBL2</span>, <span class="html-italic">CaM.2</span>, <span class="html-italic">CDPK12</span> and <span class="html-italic">CAMTA</span>) and the references in the brackets are detailed in the text. Lines ending with arrowheads represent induction, while lines with blunt ends mean inhibition.</p>
Full article ">
928 KiB  
Article
Systemic Chemokine Levels with “Gut-Specific” Vedolizumab in Patients with Inflammatory Bowel Disease—A Pilot Study
by Stephanie Zwicker, Ronaldo Lira-Junior, Charlotte Höög, Sven Almer and Elisabeth A. Boström
Int. J. Mol. Sci. 2017, 18(8), 1827; https://doi.org/10.3390/ijms18081827 - 22 Aug 2017
Cited by 8 | Viewed by 5300
Abstract
Vedolizumab, a gut-specific biological treatment for inflammatory bowel disease (IBD), is an antibody that binds to the α4β7 integrin and blocks T-cell migration into intestinal mucosa. We aimed to investigate chemokine levels in serum of IBD-patients treated with vedolizumab. In [...] Read more.
Vedolizumab, a gut-specific biological treatment for inflammatory bowel disease (IBD), is an antibody that binds to the α4β7 integrin and blocks T-cell migration into intestinal mucosa. We aimed to investigate chemokine levels in serum of IBD-patients treated with vedolizumab. In this pilot study, we included 11 IBD patients (8 Crohn’s disease, 3 ulcerative colitis) previously non-respondent to anti-tumor necrosis factor (TNF)-agents. Patients received vedolizumab at week 0, 2 and 6 and were evaluated for clinical efficacy at week 10. Clinical characteristics and routine laboratory parameters were obtained and patients were classified as responders or non-responders. Expression of 21 chemokines in serum was measured using Proximity Extension Assay and related to clinical outcome. At week 10, 6 out of 11 patients had clinically responded. Overall expression of CCL13 increased after treatment. In non-responders, expression of CCL13 and CXCL8 increased after treatment, and CCL20 and CXCL1 expressions were higher compared to responders. In responders, CCL28 decreased after treatment. C-reactive protein (CRP) correlated negatively with 6 chemokines before therapy, but not after therapy. Systemic CCL13 expression increases in IBD-patients after vedolizumab therapy and several chemokine levels differ between responders and non-responders. An increased CCL13-level when starting vedolizumab treatment, might indicate potential prognostic value of measuring chemokine levels when starting therapy with vedolizumab. This study provides new information on modulation of systemic chemokine levels after vedolizumab treatment. Full article
Show Figures

Figure 1

Figure 1
<p>Systemic chemokine levels in 11 inflammatory bowel disease-patients previously non-responding to anti-TNF-agents before and at week 10 after induction therapy with vedolizumab. (<b>A</b>) Serum levels of in total 21 chemokines in IBD-patients at baseline (week 0) and after (week 10) treatment with vedolizumab analyzed by multiplexed proximity extension assay (PEA). Serum levels of individual chemokines; (<b>B</b>) CCL13 (MCP-4); (<b>C</b>) CXCL8 (IL-8); (<b>D</b>) CCL20 (LARC); (<b>E</b>) CXCL1 (GRO-α); (<b>F</b>) CCL23 (MPIF-1); (<b>G</b>) CCL28 (MEC) divided by the clinical response into responders and non-responders. Data represent normalized protein expression (NPX) in a log2 scale mean + SEM, * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01, paired Student’s <span class="html-italic">t</span>-test; Of IBD-patients six were responders and five non-responders.</p>
Full article ">Figure 2
<p>Correlations between systemic chemokine levels and clinical parameters in 11 inflammatory bowel disease-patients previously non-responding to anti-TNF-agents before and at week 10 after induction therapy with vedolizumab. Correlations between clinical and routine laboratory parameters with chemokines (<b>A</b>) at baseline (week 0) and (<b>B</b>) after treatment (week 10) with vedolizumab. * <span class="html-italic">p</span> &lt; 0.05, Pearson correlation.</p>
Full article ">Figure 3
<p>Chemokine networks in 11 inflammatory bowel disease-patients previously non-responding to anti-TNF-agents before and at week 10 after induction therapy with vedolizumab. Network was built using the correlation coefficient between each pair of chemokines, where connection lines indicate a significant correlation (<span class="html-italic">p</span> &lt; 0.05) between chemokines (<b>A</b>) at baseline (week 0) and (<b>B</b>) after treatment (week 10) with vedolizumab. Each node represents a chemokine. The black line indicates a positive correlation and the red line indicates a negative correlation.</p>
Full article ">
17895 KiB  
Article
MiR-30a-5p Inhibits Epithelial-to-Mesenchymal Transition and Upregulates Expression of Tight Junction Protein Claudin-5 in Human Upper Tract Urothelial Carcinoma Cells
by Yueh-Hua Chung, Sung-Chou Li, Ying-Hsien Kao, Hao-Lun Luo, Yuan-Tso Cheng, Pey-Ru Lin, Ming-Hong Tai and Po-Hui Chiang
Int. J. Mol. Sci. 2017, 18(8), 1826; https://doi.org/10.3390/ijms18081826 - 22 Aug 2017
Cited by 31 | Viewed by 5679
Abstract
The involvement of microRNAs (miRNAs) in cancer development and their potential as prognostic biomarkers are becoming increasingly known. However, the signature of miRNAs and their regulatory roles in tumorigenesis of upper tract urothelial carcinoma (UTUC) remain to be elucidated. This study aimed to [...] Read more.
The involvement of microRNAs (miRNAs) in cancer development and their potential as prognostic biomarkers are becoming increasingly known. However, the signature of miRNAs and their regulatory roles in tumorigenesis of upper tract urothelial carcinoma (UTUC) remain to be elucidated. This study aimed to profile the miRNA expression pattern in UTUC tumor tissues and identify candidate miRNAs with prognostic and/or therapeutic functions. Methods and Results: We collected 22 UTUC tissue and adjacent normal tissues samples from patients who underwent nephroureterectomy. The miRNAs signatures of three selected UTUC samples using next-generation sequencing showed that miR-30a-5p was significantly downregulated in UTUC tumors compared to adjacent normal tissues. The differentially-expressed miRNAs were specifically validated by quantitative real-time polymerase chain reaction. In addition, the miRNA expression signatures were analyzed with the transcriptome profile characterized by microarray. Further in vitro studies indicated that overexpression of miR-30a-5p significantly suppressed proliferation, migration, and epithelial-to-mesenchymal transition (EMT) in cultured BFTC-909 UTUC cells. As a potential target gene of miR-30a-5p in the tight junction pathway suggested by the pathway enrichment analysis, the reduced expression of tight junction protein claudin-5 in UTUC cells was demonstrated to be upregulated by miR-30a-5p genetic delivery. Conclusions: Taken together, our findings demonstrated that miR-30a-5p inhibits proliferation, metastasis, and EMT, and upregulates the expression of tight junction claudin-5 in UTUC cells. Thus, miR-30a-5p may provide a promising therapeutic strategy for UTUC treatment. Full article
(This article belongs to the Collection Regulation by Non-coding RNAs)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Expression profiles of miRNAs in human UTUC tumor and non-tumor samples. Three tumor (T1–T3; light blue to navy blue) and three adjacent normal tissues (N1–N3; orange-yellow-green) were subjected to RNA extraction and NGS-miRNA sequencing through the Illumina MiSeq platform. (<b>A</b>) Heat-map clustering analysis was conducted to examine the overall miRNA expression profiles among samples. A line scatterplot was used to present miRNA expression profiles; (<b>B</b>) Downregulation of miR-30a-5p in UTUC tumor tissues (<span class="html-italic">n</span> = 22) compared with adjacent normal controls (<span class="html-italic">n</span> = 14) by RT-qPCR analysis. The asterisk denotes <span class="html-italic">p</span> &lt; 0.001 using an unpaired <span class="html-italic">t</span>-test.</p>
Full article ">Figure 2
<p>Comparative transcriptome analysis in human UTUC tumor and non-tumor samples. The total RNA isolated from human UTUC tumors (<span class="html-italic">n</span> = 9) and adjacent normal tissues (<span class="html-italic">n</span> = 3) was subjected to transcriptome analysis on Illumina HT12 microarray chips. The expression data was used for heat-map clustering analysis.</p>
Full article ">Figure 3
<p>KEGG pathway enrichment analysis on the tight junction pathway. The differentially-expressed genes in human UTUC tumor tissues compared to adjacent normal tissues were subjected to KEGG pathway enrichment analysis using Partek Genomics software. Note that a total of six genes (highlighted in green boxes) in the tight junction pathway, including claudin-5, were significantly downregulated in UTUC tumor tissues.</p>
Full article ">Figure 4
<p>The suppressive effect of miR-30a-5p on the proliferation and migration of UTUC cells. BFTC-909 cells were transfected with miR-30a-5p mimetic agent, followed by WST-1 and trans-well assays. NTC denotes non-transfection controls with scrambled mimetic treatment. (<b>A</b>) After mimetic transfection for 48 h, the WST-1 assay was used to evaluate cell numbers. The WST-1 value is directly proportional to cell number; (<b>B</b>) After mimetic transfection for 72 h, trans-well migration assay was performed to evaluate the cell migration ability; (<b>C</b>) The crystal violet-stained cells are those penetrating the trans-well membrane. All data are shown as means ± SEM from three independent experiments. * indicates that <span class="html-italic">p</span> &lt; 0.001 between the indicated groups.</p>
Full article ">Figure 5
<p>miR-30a-5p overexpression inhibited epithelial-to-mesenchymal transition in UTUC cells. The BFTC-909 cells transfected with miR-30a-5p were subjected to immunofluorescent staining for cellular distributions of (<b>A</b>) E-cadherin (red), vimentin (green), and nuclei (blue); (<b>C</b>) Alternatively, α-SMA (red), fibronectin (green), and nuclei (blue) were immunofluorescently visualized. The fluorescence intensities of E-cadherin and vimentin (<b>B</b>), as well as EMT markers, α-SMA, and fibronectin (<b>D</b>), were quantified by counting 5–10 different fields per sample. NTC denotes non-transfection controls with scrambled mimetic treatment. Data are expressed as means ± SEM (<span class="html-italic">n</span> = 3). * indicates that <span class="html-italic">p</span> &lt; 0.05 between the indicated groups. Original magnification: 200×.</p>
Full article ">Figure 5 Cont.
<p>miR-30a-5p overexpression inhibited epithelial-to-mesenchymal transition in UTUC cells. The BFTC-909 cells transfected with miR-30a-5p were subjected to immunofluorescent staining for cellular distributions of (<b>A</b>) E-cadherin (red), vimentin (green), and nuclei (blue); (<b>C</b>) Alternatively, α-SMA (red), fibronectin (green), and nuclei (blue) were immunofluorescently visualized. The fluorescence intensities of E-cadherin and vimentin (<b>B</b>), as well as EMT markers, α-SMA, and fibronectin (<b>D</b>), were quantified by counting 5–10 different fields per sample. NTC denotes non-transfection controls with scrambled mimetic treatment. Data are expressed as means ± SEM (<span class="html-italic">n</span> = 3). * indicates that <span class="html-italic">p</span> &lt; 0.05 between the indicated groups. Original magnification: 200×.</p>
Full article ">Figure 6
<p>miR-30a-5p overexpression inhibits epithelial-to-mesenchymal transition marker expression in UTUC cells. Western blot analysis of expression levels of epithelial marker E-cadherin (<b>A</b>), and mesenchymal markers, including vimentin (<b>B</b>), fibronectin (<b>C</b>), and α-SMA (<b>D</b>) in cultured BFTC-909 cells transfected with miR-30a-5p or miR-NC. GAPDH was used as the loading control. Data are expressed as means ± SEM (<span class="html-italic">n</span> = 3). * indicates that <span class="html-italic">p</span> &lt; 0.05 between the indicated groups.</p>
Full article ">Figure 7
<p>Claudin-5 expression is enhanced by the miR-30a-5p. The qPCR (<b>A</b>) and Western blot (<b>B</b>) analysis of <span class="html-italic">CLDN-5</span> expression levels in cultured BFTC-909 cells transfected with miR-30a-5p or miR-NC. GAPDH was used as the loading control. Data are expressed as means ± SEM (<span class="html-italic">n</span> = 3). * indicates that <span class="html-italic">p</span> &lt; 0.05 between the indicated groups.</p>
Full article ">Figure 8
<p>Proposed effects of miR-30a-5p on UTUC. The miR-30a-5p-enhanced <span class="html-italic">CLDN-5</span> expression may trigger tight junction pathway signal transduction. Moreover, miR-30a-5p suppresses the EMT process via increasing E-cadherin and suppressing vimentin, fibronectin, and α-SMA expression, thereby inhibiting the migration activity of UTUC cells.</p>
Full article ">
1361 KiB  
Review
Chemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia
by Naofumi Mukaida, Yamato Tanabe and Tomohisa Baba
Int. J. Mol. Sci. 2017, 18(8), 1824; https://doi.org/10.3390/ijms18081824 - 22 Aug 2017
Cited by 27 | Viewed by 8553
Abstract
All blood lineage cells are generated from hematopoietic stem cells (HSCs), which reside in bone marrow after birth. HSCs self-renew, proliferate, and differentiate into mature progeny under the control of local microenvironments including hematopoietic niche, which can deliver regulatory signals in the form [...] Read more.
All blood lineage cells are generated from hematopoietic stem cells (HSCs), which reside in bone marrow after birth. HSCs self-renew, proliferate, and differentiate into mature progeny under the control of local microenvironments including hematopoietic niche, which can deliver regulatory signals in the form of bound or secreted molecules and from physical cues such as oxygen tension and shear stress. Among these mediators, accumulating evidence indicates the potential involvement of several chemokines, particularly CXCL12, in the interaction between HSCs and bone marrow microenvironments. Fusion between breakpoint cluster region (BCR) and Abelson murine leukemia viral oncogene homolog (ABL)-1 gene gives rise to BCR-ABL protein with a constitutive tyrosine kinase activity and transforms HSCs and/or hematopoietic progenitor cells (HPCs) into disease-propagating leukemia stem cells (LSCs) in chronic myeloid leukemia (CML). LSCs can self-renew, proliferate, and differentiate under the influence of the signals delivered by bone marrow microenvironments including niche, as HSCs can. Thus, the interaction with bone marrow microenvironments is indispensable for the initiation, maintenance, and progression of CML. Moreover, the crosstalk between LSCs and bone marrow microenvironments can contribute to some instances of therapeutic resistance. Furthermore, evidence is accumulating to indicate the important roles of bone marrow microenvironment-derived chemokines. Hence, we will herein discuss the roles of chemokines in CML with a focus on bone marrow microenvironments. Full article
(This article belongs to the Special Issue Tumor Microenvironment)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Schematic structure of hematopoietic niche. Hematopoietic stem cells (HSCs) are found adjacent to sinusoids and arterioles throughout the bone marrow. In sinusoids, endothelial cells, CXCL12-abundant reticular (CAR) cells, and Nestin<sup>dim</sup>Lepr<sup>+</sup> perivascular cells promote HSC maintenance. Nestin<sup>bright</sup>NG<sup>+</sup> perivascular cells adjacent to arterioles support HSCs. Sympathetic cells contribute to HSC maintenance by directly regulating CXCL12 expression by MSCs. Hematopoiesis can also be regulated by other types of cells such as osteoblasts. Arrows and “T” indicate stimulating and suppressive activities, respesctively.</p>
Full article ">Figure 2
<p>Presumed roles of CXCL12 in normal hematopoiesis. CXCL12 is produced by various types of cells in bone marrow, such as endothelial cells, mesenchymal stroma cells (MSCs), and CAR cells. stromal-derived factor (SDF), HSCs are maintained and retained by CXCL12 produced by Lepr<sup>+</sup> perivascular cells in sinusoids or NG2<sup>+</sup> perivascular cells in arterioles, while lymphoid progenitor cells are maintained by osteoblast-derived CXCL12. In addition, CXCL12 regulates the development of vasculature, which is crucial for hematopoietic functions.</p>
Full article ">Figure 3
<p>Presumed roles of CCL3 in chronic myeloid leukemia (CML). A small amount of CCL3 with a potent inhibitory activity for normal HSPCs is produced constitutively by basophils under normal circumstances. In CML bone marrow, a large number of basophil-like leukemia cells are generated from LICs and produce abundantly CCL3, which inhibits normal HSPC proliferation to confer growth advantage to LICs over normal HSPCs. Black arrows indicate the differentiation pathways while the red arrow indicate the competition between normal HSCs and LICs. “T” indicates the suppressive activities.</p>
Full article ">
2763 KiB  
Article
Identification of Reference and Biomarker Proteins in Chlamydomonas reinhardtii Cultured under Different Stress Conditions
by Jianan Shi, Teng Huang, Shuaijie Chai, Yalu Guo, Jian Wei, Shijuan Dou, Liyun Li and Guozhen Liu
Int. J. Mol. Sci. 2017, 18(8), 1822; https://doi.org/10.3390/ijms18081822 - 22 Aug 2017
Cited by 17 | Viewed by 6421
Abstract
Reference proteins and biomarkers are important for the quantitative evaluation of protein abundance. Chlamydomonas reinhardtii was grown under five stress conditions (dark, cold, heat, salt, and glucose supplementation), and the OD750 and total protein contents were evaluated on days 0, 1, 2, [...] Read more.
Reference proteins and biomarkers are important for the quantitative evaluation of protein abundance. Chlamydomonas reinhardtii was grown under five stress conditions (dark, cold, heat, salt, and glucose supplementation), and the OD750 and total protein contents were evaluated on days 0, 1, 2, 4, and 6 of culture. Antibodies for 20 candidate proteins were generated, and the protein expression patterns were examined by western blotting. Reference protein(s) for each treatment were identified by calculating the Pearson’s correlation coefficient (PCC) between target protein abundance and total protein content. Histone H3, beta tubulin 1 (TUB-1), ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit (RBCL), and mitochondrial F1F0 ATP synthase subunit 6 (ATPs-6) were the top reference proteins, because they were expressed stably under multiple stress conditions. The average relative-fold change (ARF) value of each protein was calculated to identify biomarkers. Heat shock protein 90B (HSP90B), flagellar associated protein (FAP127) and ATP synthase CF0 A subunit (ATPs-A) were suitable biomarkers for multiple treatments, while receptor of activated protein kinase C1 (RCK1), biotin carboxylase (BCR1), mitochondrial phosphate carrier protein (MPC1), and rubisco large subunit N-methyltransferase (RMT1) were suitable biomarkers for the dark, cold, heat, and glucose treatments, respectively. Full article
(This article belongs to the Special Issue Selected Papers from the 6th National Plant Protein Research Congress)
Show Figures

Figure 1

Figure 1
<p>Culture appearance and cell density of <span class="html-italic">Chlamydomonas reinhardtii</span> grown under abiotic stresses. (<b>A</b>) Photos taken of <span class="html-italic">C. reinhardtii</span> at different time points during culture: control (CK), dark, cold (5 °C), heat (40 °C), NaCl (100 mM), and glucose (1% <span class="html-italic">w</span>/<span class="html-italic">v</span>); (<b>B</b>) Cell number was determined using a hemocytometer under a microscope; (<b>C</b>,<b>D</b>) Optical density of the culture at 750 nm and 680 nm in various treatments. Data are the average values from three independent experiments.</p>
Full article ">Figure 2
<p>Total protein contents of <span class="html-italic">Chlamydomonas reinhardtii</span> cells cultured under various abiotic stresses. <span class="html-italic">C. reinhardtii</span> cells were collected by centrifugation at indicated time points, and total proteins were extracted and separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). (<b>A</b>–<b>C</b>). Coomassie Brilliant Blue-stained gels. (<b>D</b>). Signals extracted from A–C by Lane 1D software. To normalize data collected from different gels, value at day 0 was set to one and fold changes at other time points were calculated. Data are average values from three independent experiments. Cells were grown without stress (CK, control) or in the dark, cold (5 °C), heat (40 °C), or with NaCl or glucose supplementation. Samples were collected on days 0, 1, 2, 4, and 6 of culture.</p>
Full article ">Figure 3
<p>Recombinant protein expression and antibody verification. Candidate genes (<span class="html-italic">RCK1</span>, <span class="html-italic">OEE2</span>, <span class="html-italic">FKBP12</span>, and <span class="html-italic">HSP70A</span>-N terminal sequence) were cloned into expression vector pET30a and transformed into <span class="html-italic">Escherichia coli</span>. Expression of recombinant proteins was induced by adding isopropyl β-<span class="html-small-caps">d</span>-1-thiogalactopyranoside (IPTG) to lysogeny broth (LB) medium. <span class="html-italic">E. coli</span> cells were collected by centrifugation and total proteins were extracted after sonication. Supernatant and pellet samples were separated by centrifugation. Recombinant proteins in pellet form were washed in 2 M urea and then dissolved in 8 M urea. SDS-PAGE-separated proteins were visualized by Coomassie Blue staining. Dissolved recombinant protein was used to generate polyclonal antibodies. To verify the specificity of antibodies, Western blotting analysis was carried out against dissolved proteins. M: molecular weight marker; 0 h: samples collected at 0 h; S: supernatant samples collected at 3 h after IPTG induction. P: pellet samples collected at 3 h after IPTG induction; 2 M: pellet samples washed with 2 M urea; 8 M: pellet samples dissolved in 8 M urea; WB: SDS-PAGE-separated proteins were immobilized on polyvinylidene difluoride (PVDF) membrane and detected with antibodies against recombinant proteins.</p>
Full article ">Figure 4
<p>Western blot detection of candidate proteins in <span class="html-italic">Chlamydomonas reinhardtii</span> cells under abiotic stresses at different time points. <span class="html-italic">C. reinhardtii</span> cells cultured under different abiotic stress conditions were collected at five time points. Total proteins were extracted and separated by SDS-PAGE. PVDF-membrane-immobilized proteins were detected by antibodies against 20 candidate proteins. CK, Dark, 5 °C, 40 °C, NaCl, and Glucose are treatments for <span class="html-italic">C. reinhardtii</span> cells. D0, D1, D2, D4, and D6 are the time points (days) of sample collection.</p>
Full article ">Figure 5
<p>Average relative fold change (ARF) of candidate proteins and selected biomarkers. ARFs calculated for candidate proteins are illustrated by different colored bars (see key). For each protein, ARF was calculated as follows: ∑1, 2, 4, 6(I(Treatment) − I(CK))/I(CK))/4, where 1, 2, 4, and 6 are days 1, 2, 4, and 6, respectively, I(treatment) is normalized intensity of Western blot for specific treatment at n (1, 2, 4, or 6) time points, and I(CK) is the normalized intensity of the Western blot for the control (CK). “*” indicates the recommended biomarker with highest ARF under multiple or specific treatments. (<b>A</b>) ARF value of HSP90B was highlighted with “*” indicating it is a wide-range biomarker for five treatments. HSP90B data were excluded in (<b>B</b>–<b>G</b>) and “*” designated the recommended biomarkers respectively. (<b>B</b>) highlights the ARF of FAP127. (<b>C</b>) highlights the ARF of ATPs-A. RCK1 is highlighted with “*” in (<b>D</b>), BCR1 in (<b>E</b>), MPC1 in (<b>F</b>) and RMT1 in (<b>G</b>).</p>
Full article ">
945 KiB  
Review
Principal Aspects Regarding the Maintenance of Mammalian Mitochondrial Genome Integrity
by Panagiotis V. S. Vasileiou, Iordanis Mourouzis and Constantinos Pantos
Int. J. Mol. Sci. 2017, 18(8), 1821; https://doi.org/10.3390/ijms18081821 - 22 Aug 2017
Cited by 20 | Viewed by 6443
Abstract
Mitochondria have emerged as key players regarding cellular homeostasis not only due to their contribution regarding energy production through oxidative phosphorylation, but also due to their involvement in signaling, ion regulation, and programmed cell death. Indeed, current knowledge supports the notion that mitochondrial [...] Read more.
Mitochondria have emerged as key players regarding cellular homeostasis not only due to their contribution regarding energy production through oxidative phosphorylation, but also due to their involvement in signaling, ion regulation, and programmed cell death. Indeed, current knowledge supports the notion that mitochondrial dysfunction is a hallmark in the pathogenesis of various diseases. Mitochondrial biogenesis and function require the coordinated action of two genomes: nuclear and mitochondrial. Unfortunately, both intrinsic and environmental genotoxic insults constantly threaten the integrity of nuclear as well as mitochondrial DNA. Despite the extensive research that has been made regarding nuclear genome instability, the importance of mitochondrial genome integrity has only recently begun to be elucidated. The specific architecture and repair mechanisms of mitochondrial DNA, as well as the dynamic behavior that mitochondria exert regarding fusion, fission, and autophagy participate in mitochondrial genome stability, and therefore, cell homeostasis. Full article
(This article belongs to the Special Issue Mechanisms Leading to Genomic Instability)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The level of mitochondrial DNA damage determines whether mitophagy or cell death will be stimulated. ATM (ATM serine/threonine kinase), p53 and Sirt1 (sirtuin 1) mediate the signaling between the nucleus and the mitochondria.</p>
Full article ">Figure 2
<p>Factors with which Sirt1 interacts regarding mitochondrial homeostasis. [PGC1a: peroxisome proliferator-activated receptor gamma co-activator (PGC1a), HIF1a: hypoxia-inducible factor 1-alpha, AMPK: 5′ adenosine monophosphate-activated protein kinase].</p>
Full article ">Figure 3
<p>Summary of factors mentioned in the text that are associated with instability of mammalian mitochondrial DNA. The list presented herein is not exhaustive. (Polγ: polymerase γ, mtSSB: mitochondrial single stranded DNA binding protein, TFAM: mitochondrial transcription factor A, NRF1/2: nuclear respiratory factors 1 and 2, PrimPol: primase-polymerase; Pif1: petite integration frequency 1, BER: base excision repair, Mfn: mitofusin, Opa1: optic atrophy protein 1,Drp1: dynamin related protein 1,hFIS1: fission 1 protein, Mff: mitochondrial fission factor, MiD49/51: mitochondrial dynamics proteins of 49 and 51 kDa, RRM2B: ribonucleoside-diphosphate reductase subunit M2 B).</p>
Full article ">Figure 4
<p>Proteins involved in the maintenance of mitochondrial DNA integrity, in addition to their role in ensuring nuclear genomic homeostasis. (BRCA1: breast cancer type 1 protein, CtIP: CtBP-interacting protein, FEN1: flap endonuclease 1, MRE11: meiotic recombination 11, PARP: poly (ADP-ribose) polymerase).</p>
Full article ">
3959 KiB  
Article
GLUT10—Lacking in Arterial Tortuosity Syndrome—Is Localized to the Endoplasmic Reticulum of Human Fibroblasts
by Alessandra Gamberucci, Paola Marcolongo, Csilla E. Németh, Nicoletta Zoppi, András Szarka, Nicola Chiarelli, Tamás Hegedűs, Marco Ritelli, Giulia Carini, Andy Willaert, Bert L. Callewaert, Paul J. Coucke, Angiolo Benedetti, Éva Margittai, Rosella Fulceri, Gábor Bánhegyi and Marina Colombi
Int. J. Mol. Sci. 2017, 18(8), 1820; https://doi.org/10.3390/ijms18081820 - 22 Aug 2017
Cited by 17 | Viewed by 5552
Abstract
GLUT10 belongs to a family of transporters that catalyze the uptake of sugars/polyols by facilitated diffusion. Loss-of-function mutations in the SLC2A10 gene encoding GLUT10 are responsible for arterial tortuosity syndrome (ATS). Since subcellular distribution of the transporter is dubious, we aimed to clarify [...] Read more.
GLUT10 belongs to a family of transporters that catalyze the uptake of sugars/polyols by facilitated diffusion. Loss-of-function mutations in the SLC2A10 gene encoding GLUT10 are responsible for arterial tortuosity syndrome (ATS). Since subcellular distribution of the transporter is dubious, we aimed to clarify the localization of GLUT10. In silico GLUT10 localization prediction suggested its presence in the endoplasmic reticulum (ER). Immunoblotting showed the presence of GLUT10 protein in the microsomal, but not in mitochondrial fractions of human fibroblasts and liver tissue. An even cytosolic distribution with an intense perinuclear decoration of GLUT10 was demonstrated by immunofluorescence in human fibroblasts, whilst mitochondrial markers revealed a fully different decoration pattern. GLUT10 decoration was fully absent in fibroblasts from three ATS patients. Expression of exogenous, tagged GLUT10 in fibroblasts from an ATS patient revealed a strict co-localization with the ER marker protein disulfide isomerase (PDI). The results demonstrate that GLUT10 is present in the ER. Full article
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>GLUT10 is present in the microsomal fraction of human fibroblasts and liver tissue. Subcellular fractions were prepared from human skin fibroblasts (<b>A</b>) or human liver tissue (<b>B</b>) and analyzed by Western blot after SDS-page separation of proteins, with antibodies to the GLUT10 protein as well as the marker proteins Grp94 for microsomes, VDAC1 and cyclophilin D for mitochondria, and GAPDH for the cytosol, as detailed in the “Experimental” section. Abbreviations: N: Nuclei; MT: mitochondria; Cyt: cytosol; MS: microsomes; Ho: homogenate; PNS: post nuclear supernatant.</p>
Full article ">Figure 2
<p>GLUT10 and mitochondrial immunostaining in fibroblasts from human healthy subjects and three arterial tortuosity syndrome (ATS) patients. Fibroblasts were prepared and immunoreacted with the anti-GLUT10 antibody Ab1 and an antibody to Cyt C, and the images were acquired by fluorescent microscopy as detailed in the “Experimental” section. P1, P2 and P3 indicate three unrelated ATS patients as described in the “Experimental” section. Scale bar = 5 μm.</p>
Full article ">Figure 3
<p>GLUT10 immunostaining and mitochondrial decoration with a fluorescent probe in the human fibroblast cell line BJ-5ta. Human fibroblast immortalized with hTERT (BJ-5ta line) were immunoreacted with the anti-GLUT10 antibody Ab2, and the mitochondrial fluorescent probe Mito Tracker™ Orange as reported in the “Experimental” section. Images were acquired by fluorescent microscopy as detailed in the “Experimental” section. Scale bar = 5 μm.</p>
Full article ">Figure 4
<p>GLUT10 co-localizes with the ER marker protein disulfide isomerase (PDI). Tagged GLUT10 was transiently transfected in fibroblasts of the ATS patient P1 that were immunoreacted with antibodies to the GLUT10 tag and the ER marker PDI as reported in the “Experimental” section. The images were acquired by fluorescent microscopy as detailed in the “Experimental” section. Scale bar = 10 μm.</p>
Full article ">
743 KiB  
Communication
Impact of Platelet-Rich Plasma on Viability and Proliferation in Wound Healing Processes after External Radiation
by Yvonne Reinders, Oliver Felthaus, Gero Brockhoff, Fabian Pohl, Norbert Ahrens, Lukas Prantl and Frank Haubner
Int. J. Mol. Sci. 2017, 18(8), 1819; https://doi.org/10.3390/ijms18081819 - 22 Aug 2017
Cited by 17 | Viewed by 5668
Abstract
Platelet-rich plasma is a current subject of studies on chronic wound healing therapy due to possible pro-angiogenic effects. Microvascular compromise represents the major component in radiogenic wound healing complications. The effects of platelet-rich plasma on irradiated cells of the cutaneous wound healing process [...] Read more.
Platelet-rich plasma is a current subject of studies on chronic wound healing therapy due to possible pro-angiogenic effects. Microvascular compromise represents the major component in radiogenic wound healing complications. The effects of platelet-rich plasma on irradiated cells of the cutaneous wound healing process are poorly understood so far. In this study, the interaction of endothelial cells and adipose-derived stem cells in conjunction with treatment with platelet-rich plasma is investigated in the context of radiation effects. Therefore, the expression of surface-marker CD90 and CD31 was determined. Moreover, cell proliferation and viability after external radiation was analyzed with and without treatment by platelet-rich plasma. Full article
(This article belongs to the Special Issue Molecular Research of Epidermal Stem Cells 2017)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Flow cytometric analysis of the surface markers CD90 and CD31. CD31 is highlighted in light grey, CD90 in dark grey. Samples were treated with 5% platelet-rich plasma and irradiated using a dose of 2 Gy (J/kg). Data for control cells are given. (<b>a</b>) Comparison of adipose-derived stem cells in α-MEM and adipose-derived stem cells in EC-Medium; (<b>b</b>) Analysis of CD90 and CD31 of adipose-derived stem cells, microvascular endothelial cells and the respective co-culture.</p>
Full article ">Figure 2
<p>Cell viability determined from adipose-derived stem cells. (<b>a</b>) Human dermal endothelial microvascular cells; (<b>b</b>) and co-cultures of the respective cell lines; (<b>c</b>) upon external radiation and treatment with platelet-rich plasma using a WST-8 assay. Values are represented as means ± standard deviations. Statistical significances of * <span class="html-italic">p</span> ≤ 0.05, ** <span class="html-italic">p</span> ≤ 0.01 and *** <span class="html-italic">p</span> ≤ 0.001 are indicated, respectively.</p>
Full article ">Figure 3
<p>Cell proliferation of ASC, HDMEC and the corresponding co-culture upon treatment with PRP was determined using a BrdU assay. Error bars represent standard deviation. Values are represented as means ± standard deviations. Statistical significances of * <span class="html-italic">p</span> ≤ 0.05, ** <span class="html-italic">p</span> ≤ 0.01 and *** <span class="html-italic">p</span> ≤ 0.001 are indicated, respectively.</p>
Full article ">
912 KiB  
Case Report
Peritoneal Mesothelioma with Residential Asbestos Exposure. Report of a Case with Long Survival (Seventeen Years) Analyzed by Cgh-Array
by Gabriella Serio, Federica Pezzuto, Andrea Marzullo, Anna Scattone, Domenica Cavone, Alessandra Punzi, Francesco Fortarezza, Mattia Gentile, Antonia Lucia Buonadonna, Mattia Barbareschi and Luigi Vimercati
Int. J. Mol. Sci. 2017, 18(8), 1818; https://doi.org/10.3390/ijms18081818 - 22 Aug 2017
Cited by 27 | Viewed by 4710
Abstract
Malignant mesothelioma is a rare and aggressive tumor with limited therapeutic options. We report a case of a malignant peritoneal mesothelioma (MPM) epithelioid type, with environmental asbestos exposure, in a 36-year-old man, with a long survival (17 years). The patient received standard treatment [...] Read more.
Malignant mesothelioma is a rare and aggressive tumor with limited therapeutic options. We report a case of a malignant peritoneal mesothelioma (MPM) epithelioid type, with environmental asbestos exposure, in a 36-year-old man, with a long survival (17 years). The patient received standard treatment which included cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). Methods and Results: Molecular analysis with comparative genomic hybridization (CGH)-array was performed on paraffin-embedded tumoral samples. Multiple chromosomal imbalances were detected. The gains were prevalent. Losses at 1q21, 2q11.1→q13, 8p23.1, 9p12→p11, 9q21.33→q33.1, 9q12→q21.33, and 17p12→p11.2 are observed. Chromosome band 3p21 (BAP1), 9p21 (CDKN2A) and 22q12 (NF2) are not affected. Conclusions: the defects observed in this case are uncommon in malignant peritoneal mesothelioma. Some chromosomal aberrations that appear to be random here, might actually be relevant events explaining the response to therapy, the long survival and, finally, may be considered useful prognostic factors in peritoneal malignant mesothelioma (PMM). Full article
(This article belongs to the Special Issue Mesothelioma Heterogeneity: Potential Mechanisms)
Show Figures

Figure 1

Figure 1
<p>Malignant peritoneal mesothelioma: histology, immunohistochemical (IHC) and comparative genomic hybridization (CGH)-array results.</p>
Full article ">
338 KiB  
Review
Current Advances in Thyroid Cancer Management. Are We Ready for the Epidemic Rise of Diagnoses?
by Dagmara Rusinek, Ewa Chmielik, Jolanta Krajewska, Michal Jarzab, Malgorzata Oczko-Wojciechowska, Agnieszka Czarniecka and Barbara Jarzab
Int. J. Mol. Sci. 2017, 18(8), 1817; https://doi.org/10.3390/ijms18081817 - 22 Aug 2017
Cited by 35 | Viewed by 7041
Abstract
A rising incidence of thyroid cancers (TCs) mainly small tumors, observed during recent years, lead to many controversies regarding treatment strategies. TCs represent a distinct molecular background and clinical outcome. Although in most cases TCs are characterized by a good prognosis, there are [...] Read more.
A rising incidence of thyroid cancers (TCs) mainly small tumors, observed during recent years, lead to many controversies regarding treatment strategies. TCs represent a distinct molecular background and clinical outcome. Although in most cases TCs are characterized by a good prognosis, there are some aggressive forms, which do not respond to standard treatment. There are still some questions, which have to be resolved to avoid dangerous simplifications in the clinical management. In this article, we focused on the current advantages in preoperative molecular diagnostic tests and histopathological examination including noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP). We discussed the controversies regarding the extent of thyroid surgery and adjuvant radioiodine therapy, as well as new treatment modalities for radioiodine-refractory differentiated thyroid cancer (RR-DTC). Considering medullary thyroid cancer (MTC), we analyzed a clinical management based on histopathology and RET (ret proto-oncogene) mutation genotype, disease follow-up with a special attention to serum calcitonin doubling time as an important prognostic marker, and targeted therapy applied in advanced MTC. In addition, we provided some data regarding anaplastic thyroid cancer (ATC), a highly lethal neoplasm, which lead to death in nearly 100% of patients due to the lack of effective treatment options. Full article
(This article belongs to the Special Issue Cell and Molecular Biology of Thyroid Disorders)
Show Figures

Graphical abstract

Graphical abstract
Full article ">
1292 KiB  
Article
Bioaccessibility, Intestinal Permeability and Plasma Stability of Isorhamnetin Glycosides from Opuntia ficus-indica (L.)
by Marilena Antunes-Ricardo, César Rodríguez-Rodríguez, Janet A. Gutiérrez-Uribe, Eduardo Cepeda-Cañedo and Sergio O. Serna-Saldívar
Int. J. Mol. Sci. 2017, 18(8), 1816; https://doi.org/10.3390/ijms18081816 - 22 Aug 2017
Cited by 41 | Viewed by 5745
Abstract
Isorhamnetin glycosides are representative compounds of Opuntia ficus-indica that possess different biological activities. There is slight information about the changes in bioaccessibility induced by the glycosylation pattern of flavonoids, particularly for isorhamnetin. In this study, the bioaccessibility and permeability of isorhamnetin glycosides extracted [...] Read more.
Isorhamnetin glycosides are representative compounds of Opuntia ficus-indica that possess different biological activities. There is slight information about the changes in bioaccessibility induced by the glycosylation pattern of flavonoids, particularly for isorhamnetin. In this study, the bioaccessibility and permeability of isorhamnetin glycosides extracted from O. ficus-indica were contrasted with an isorhamnetin standard. Also, the plasma stability of these isorhamnetin glycosides after intravenous administration in rats was evaluated. Recoveries of isorhamnetin after oral and gastric digestion were lower than that observed for its glycosides. After intestinal digestion, isorhamnetin glycosides recoveries were reduced to less than 81.0%. The apparent permeability coefficient from apical (AP) to basolateral (BL) direction (Papp(AP-BL)) of isorhamnetin was 2.6 to 4.6-fold higher than those obtained for its glycosides. Isorhamnetin diglycosides showed higher Papp(AP-BL) values than triglycosides. Sugar substituents affected the Papp(AP-BL) of the triglycosides. Isorhamnetin glycosides were better retained in the circulatory system than the aglycone. After intravenous dose of the isorhamnetin standard, the elimination half-life was 0.64 h but increased to 1.08 h when the O. ficus-indica extract was administered. These results suggest that isorhamnetin glycosides naturally found in O. ficus-indica could be a controlled delivery system to maintain a constant plasmatic concentration of this important flavonoid to exert its biological effects in vivo. Full article
(This article belongs to the Special Issue Bioactive Phenolics and Polyphenols 2018)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Chemical structures of isorhamnetin glycosides found in <span class="html-italic">O. ficus-indica</span> extract. Glc = glucose; Rha = rhamnose; Pen = pentose.</p>
Full article ">Figure 2
<p>Comparison between permeability of isorhamnetin glycosides from <span class="html-italic">O. ficus-indica</span> extract and isorhamnetin standard in a Caco-2/HT-29 cell monolayer. (<b>a</b>) Apparent permeability (Papp) of isorhamnetin glycosides (IGRR, IGRP, IGP, IGR) and isorhamnetin standard from apical to basolateral (AP-BL), and basolateral to apical compartment (BL-AP); (<b>b</b>) efflux ratio of isorhamnetin glycosides (IGRR, IGRP, IGP, IGR) and isorhamnetin standard. Data was expressed as mean ± standard deviation. IGRR: isorhamnetin-3-<span class="html-italic">O</span>-glucosyl-rhamnosyl-rhamnoside; IGRP: isorhamnetin-3-<span class="html-italic">O</span>-glucosyl-rhamnosyl-pentoside; IGP: isorhamnetin-3-<span class="html-italic">O</span>-glucosyl-pentoside; IGR: isorhamnetin-3-<span class="html-italic">O</span>-glucosyl-rhamnoside; I: isorhamnetin. Different letters indicate significant differences among different isorhamnetin glycosides. Efflux ratio was calculated by the relation between Papp<sub>(BL-AP)</sub>/Papp<sub>(AP-BL)</sub>.</p>
Full article ">Figure 3
<p>Chromatograms showing isorhamnetin release from isorhamnetin glycosides contained in <span class="html-italic">O. ficus-indica</span> extract, using (<b>a</b>) 20 min; (<b>b</b>) 90 min; or (<b>c</b>) 180 min of acid hydrolysis; (<b>d</b>) isorhamnetin recovery percentages obtained after 20, 90, or 180 min of acid hydrolysis. Different letters indicate significant differences among different isorhamnetin glycosides.</p>
Full article ">Figure 4
<p>Isorhamnetin concentration (µmol·L<sup>−1</sup>) in rat plasma and pharmacokinetic parameters after an intravenous dose (2 mg/kg) of an <span class="html-italic">O. ficus-indica</span> extract or isorhamnetin standard.</p>
Full article ">
6958 KiB  
Article
Successive Onset of Molecular, Cellular and Tissue-Specific Responses in Midgut Gland of Littorina littorea Exposed to Sub-Lethal Cadmium Concentrations
by Denis Benito, Michael Niederwanger, Urtzi Izagirre, Reinhard Dallinger and Manu Soto
Int. J. Mol. Sci. 2017, 18(8), 1815; https://doi.org/10.3390/ijms18081815 - 22 Aug 2017
Cited by 24 | Viewed by 5560
Abstract
Cadmium (Cd) is one of the most harmful metals, being toxic to most animal species, including marine invertebrates. Among marine gastropods, the periwinkle (Littorina littorea) in particular can accumulate high amounts of Cd in its midgut gland. In this organ, the [...] Read more.
Cadmium (Cd) is one of the most harmful metals, being toxic to most animal species, including marine invertebrates. Among marine gastropods, the periwinkle (Littorina littorea) in particular can accumulate high amounts of Cd in its midgut gland. In this organ, the metal can elicit extensive cytological and tissue-specific alterations that may reach, depending on the intensity of Cd exposure, from reversible lesions to pathological cellular disruptions. At the same time, Littorina littorea expresses a Cd-specific metallothionein (MT) that, due to its molecular features, expectedly exerts a protective function against the adverse intracellular effects of this metal. The aim of the present study was, therefore, to assess the time course of MT induction in the periwinkle’s midgut gland on the one hand, and cellular and tissue-specific alterations in the digestive organ complex (midgut gland and digestive tract) on the other, upon exposure to sub-lethal Cd concentrations (0.25 and 1 mg Cd/L) over 21 days. Depending on the Cd concentrations applied, the beginning of alterations of the assessed parameters followed distinct concentration-dependent and time-dependent patterns, where the timeframe for the onset of the different response reactions became narrower at higher Cd concentrations compared to lower exposure concentrations. Full article
(This article belongs to the Special Issue Metal Metabolism in Animals II)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Cd accumulation in the digestive gland of the control (blue lines and symbols) and Cd-exposed winkles (grey line and symbols: CdL = 0.25 mg Cd /L; black line and symbols: CdH = 1 mg Cd /L). Mean values and standard deviations (<span class="html-italic">n</span> = 4) are shown. The significance of the accumulation curves (CdL and CdH) was confirmed by ANOVA (<span class="html-italic">p</span> ≤ 0.001). The significant differences of values between Cd-exposed and control individuals at different time points (Holm–Sidak pairwise multiple comparison, significance level 0.05) are indicated by different letters. Sampling points during the first 24 h (Day 1) are under-laid in blue.</p>
Full article ">Figure 2
<p>Autometallography staining of the midgut gland of winkles. (<b>A</b>) Controls, black silver deposits (BSD) in the basal lamina (arrows) of midgut gland tubuli (scale bar: 100 µm); (<b>B</b>) CdH (21 days), BSD in digestive cell lysosomes (arrowheads) and in the basal lamina (arrows) of midgut gland tubules. Note the presence of BSD within hemocytes (H) of the interstitial connective tissue (scale bar: 50 µm); (<b>C</b>) CdH (21 days), detail of BSD in digestive cell (DC) lysosomes (arrowheads) near the tubular lumen (L) and in the basal lamina (arrows) of a midgut gland tubule (scale bar: 20 µm); (<b>D</b>) CdH (21 days), BSD in the basal lamina of the epithelium of the stomach (arrows), in the lysosomes of epithelial cells (arrowheads) and in hemocytes (H) of the connective tissue (scale bar: 50 µm); (<b>E</b>) CdH (21days), inset of figure (<b>D</b>) (square), showing in detail BSD in hemocytes and in the basal lamina of the stomach epithelium (arrows).</p>
Full article ">Figure 3
<p>(<b>A</b>) Translated protein sequences of allelic variants of <span class="html-italic">Littorina littorea</span>, all of them caused by single nucleotide polymorphisms (SNPs) in the coding region of the respective gene. The sequence variants (Littvar1, Littvar2, Littvar3, Littvar4, Littvar5) are aligned with the first reported reference sequence (LittRef) of the <span class="html-italic">Littorina littorea</span> MT (GenBank Acc.Nr.: AY034179.1) [<a href="#B31-ijms-18-01815" class="html-bibr">31</a>]. Exchanged amino acid residues in the allelic variants are marked in blue. The tri-partite structure of the protein into different domains is indicated by blue (α domains) and red frames (β domain) [<a href="#B37-ijms-18-01815" class="html-bibr">37</a>]. The allelic variant sequences are available from GenBank under the acc. nrs.: KY963497 (Littvar 1), KY963498 (Littvar2), KY963499 (Littvar3), KY963500 (Littvar4) and KY963501 (Littvar5); (<b>B</b>) mRNA transcription of the Cd metallothionein (MT) gene of <span class="html-italic">Littorina littorea</span> in control animals (Control, blue line and symbols) and in winkles exposed to nominal Cd concentrations of 0.25 mg/L (CdL, grey line and symbols) and 1.00 mg/L (CdH, black line and symbols) over a period of 21 days. Mean values and standard deviations (<span class="html-italic">n</span> = 4) are shown. The significance of the mRNA transcription curves was confirmed by ANOVA (<span class="html-italic">p</span> ≤ 0.001). The significant differences of values between Cd-exposed and control individuals at different time points (Holm–Sidak pairwise multiple comparison, significance level 0.05) are indicated by different letters (A, B, C). Sampling points during the first 24 h (Day 1) are under-laid in blue.</p>
Full article ">Figure 4
<p>(<b>A</b>) Concentration factor for Cd in the midgut gland of <span class="html-italic">Littorina littorea</span>. Blue bars represent the low Cd exposure group (CdL), the red bars represent the high Cd exposure group (CdH). All values refer to respective control concentrations at the beginning of the experiment; (<b>B</b>) Fold induction factor for the increase of the MT mRNA concentration. Blue bars represent the low Cd exposure group (CdL). Red bars represent the high Cd exposure group (CdH). All values refer to the respective control mRNA copy numbers at the beginning of the experiment (set to 1).</p>
Full article ">Figure 5
<p>(<b>A</b>) Progression of volume density of lysosomes (Vv<sub>LYS</sub>) in the digestive cells of midgut gland tubules of <span class="html-italic">Littorina littorea</span>. Means (symbols) and standard errors (bars) are shown. Different letter codes between single values of the same time point indicate statistically significant differences (<span class="html-italic">p</span> &lt; 0.05); (<b>B</b>) Course of integrity loss of digestive cells (DCI) in the midgut gland tubular epithelium, expressed in arbitrary units (a.u.) (see <a href="#ijms-18-01815-t001" class="html-table">Table 1</a> in the Materials and Methods section for explanation). Means (symbols) and standard errors (bars) are shown. Different letter codes between single values of the same time point indicate statistically significant differences (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 6
<p>Lipofuscin staining in digestive cells of the tubular epithelium in the midgut gland of (<b>A</b>) a control periwinkle and; (<b>B</b>) an individual of the CdH group after 21 days of exposure. Scale bars: 200 µm; arrows indicate lipofuscin granules.</p>
Full article ">Figure 7
<p>(<b>A</b>) Time course of volume density of basophilic cells (V<sub>VBAS</sub>) in the midgut gland tubules of <span class="html-italic">Littorina littorea</span>. Means (symbols) and standard errors (bars) are shown. Different letter codes between single values of the same time point indicate statistically significant differences (<span class="html-italic">p</span> &lt; 0.05); (<b>B</b>) Progression of the presence of connective tissue calcium cells (CTCA) in the midgut gland of periwinkles, expressed in arbitrary units (a.u.) (see <a href="#ijms-18-01815-t001" class="html-table">Table 1</a> in the Materials and Methods section for explanation). Means (symbols) and standard errors (bars) are shown. Different letter codes between single values of the same time point indicate statistically significant differences (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 8
<p>(<b>A</b>) Detailed view of the midgut gland tubules (hematoxylin-eosin staining) of a control periwinkle and (<b>B</b>) of a periwinkle of the CdH group after an exposure of 21 days. Note the drastic increase of the relative number of basophilic cells (arrows) and the enlarged lumen in (<b>B</b>), compared to control conditions (<b>A</b>). Scale bars: 200 µm; Abbreviations: L: lumen, DC: digestive cells, BC: basophilic cells.</p>
Full article ">Figure 9
<p>Overall view of the midgut gland/gonad complex stained with hematoxylin-eosin. (<b>A</b>) control periwinkle (male); (<b>B</b>) a periwinkle of the CdH group after 21 days of exposure (female). Scale bars: 200 µm; Abbreviations: DD: digestive tubular diverticula, CA: Connective Tissue Calcium cells, CT: connective tissue; GO: gonad tissue.</p>
Full article ">Figure 10
<p>(<b>A</b>) Progression of structural integrity in the midgut gland/gonad complex of <span class="html-italic">Littorina littorea</span>, expressed by the connective tissue to digestive tubule ratio (CTDr). Means (symbols) and standard errors (bars) are shown. Different letter codes between single values of the same time point indicate statistically significant differences (<span class="html-italic">p</span> &lt; 0.05); (<b>B</b>) Progression of lumen visibility of midgut gland tubules, expressed in arbitrary units (a.u.) (see <a href="#ijms-18-01815-t001" class="html-table">Table 1</a> in the Materials and Methods section for explanation). Means (symbols) and standard errors (bars) are shown. Different letter codes between single values of the same time point indicate statistically significant differences (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 11
<p>Course of the integrity loss of the epithelia of digestive tract (DTI), expressed in arbitrary units (a.u.) (see <a href="#ijms-18-01815-t001" class="html-table">Table 1</a> in the Materials and Methods section for explanation). Means (symbols) and standard errors (bars) are shown. Different letter codes between single values of the same time point indicate statistically significant differences (<span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 12
<p>Sections of the stomach (digestive tract) stained with hematoxylin-eosin. (<b>A</b>) Control periwinkle; (<b>B</b>) Periwinkle of the CdH group after 21 days of exposure. Note the loss of integrity in the stomach epithelium (arrows) and the increase of mucocytes as a result of Cd-exposure. Scale bars: 200 µm; Abbreviations: DE: Digestive epithelia, BL: Basal lamina, MU: Mucocytes.</p>
Full article ">Figure 13
<p>Time course of the onset of molecular (red), cellular (green) and tissue-specific alterations (blue) in <span class="html-italic">Littorina littorea</span> exposed to sub-lethal low (CdL) (<b>A</b>) and high (CdH) (<b>B</b>) Cd concentrations through 21 days of exposure, followed by a 12 days period of recovery. Abbreviations: MT mRNA: MT mRNA copy numbers, Vv<sub>LYS</sub>: Volume Density of lysosomes in digestive cells of midgut gland tubules, DCI: Digestive cell integrity of midgut gland tubules; CTCA: presence of connective tissue calcium cells in the midgut gland, V<sub>VBAS</sub>: Volume density of basophilic cells in the epithelium of midgut gland tubules, DTI: Digestive tract integrity. CTDr: Connective tissue to digestive tubule ratio.</p>
Full article ">
2809 KiB  
Article
The Herbal Bitter Drug Gentiana lutea Modulates Lipid Synthesis in Human Keratinocytes In Vitro and In Vivo
by Ute Wölfle, Birgit Haarhaus, Jasmin Seiwerth, Anja Cawelius, Kay Schwabe, Karl-Werner Quirin and Christoph M. Schempp
Int. J. Mol. Sci. 2017, 18(8), 1814; https://doi.org/10.3390/ijms18081814 - 22 Aug 2017
Cited by 31 | Viewed by 7208
Abstract
Gentiana lutea is a herbal bitter drug that is used to enhance gastrointestinal motility and secretion. Recently we have shown that amarogentin, a characteristic bitter compound of Gentiana lutea extract (GE), binds to the bitter taste receptors TAS2R1 and TAS2R38 in human keratinocytes, [...] Read more.
Gentiana lutea is a herbal bitter drug that is used to enhance gastrointestinal motility and secretion. Recently we have shown that amarogentin, a characteristic bitter compound of Gentiana lutea extract (GE), binds to the bitter taste receptors TAS2R1 and TAS2R38 in human keratinocytes, and stimulates the synthesis of epidermal barrier proteins. Here, we wondered if GE also modulates lipid synthesis in human keratinocytes. To address this issue, human primary keratinocytes were incubated for 6 days with GE. Nile Red labeling revealed that GE significantly increased lipid synthesis in keratinocytes. Similarly, gas chromatography with flame ionization detector indicated that GE increases the amount of triglycerides in keratinocytes. GE induced the expression of epidermal ceramide synthase 3, but not sphingomyelinase. Lipid synthesis, as well as ceramide synthase 3 expression, could be specifically blocked by inhibitors of the p38 MAPK and PPARγ signaling pathway. To assess if GE also modulates lipid synthesis in vivo, we performed a proof of concept half side comparison on the volar forearms of 33 volunteers. In comparison to placebo, GE significantly increased the lipid content of the treated skin areas, as measured with a sebumeter. Thus, GE enhances lipid synthesis in human keratinocytes that is essential for building an intact epidermal barrier. Therefore, GE might be used to improve skin disorders with an impaired epidermal barrier, e.g., very dry skin and atopic eczema. Full article
(This article belongs to the Special Issue Inflammatory Skin Conditions 2017)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Illustration of the differentiation process in keratinocytes. The triangles indicate increasing or decreasing concentrations of the respective molecules within the epidermis. Bcl-2—B-cell lymphoma 2; BAK—Bcl-2 antagonist/killer1; MDM2—mouse double minute 2 homolog; Ca<sup>2+</sup>—calcium. The graphic was adapted from [<a href="#B12-ijms-18-01814" class="html-bibr">12</a>].</p>
Full article ">Figure 2
<p><span class="html-italic">Gentiana lutea</span> extract (GE) enhances lipid synthesis in hPK. (<b>A</b>–<b>D</b>) HPKs were treated with 200 µg/mL GE (unless otherwise stated) for 6 days. The graph in (<b>A</b>,<b>B</b>) reports the quantitative measurement of intracellular neutral lipids as assessed after Nile Red labeling. Graph C shows cell viability as assessed with the ViaLight Plus bioassay kit; Graph (<b>D</b>) shows the qualitative measurement of intracellular neutral lipids after labeled by Nile Red; the nuclei were counterstained with DAPI. The white arrows point to lipid droplets. (ns: not significant, * <span class="html-italic">p</span> &lt; 0.05; ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001). The pictures were photographed at a magnification of 400×. The bar indicates 10 µm.</p>
Full article ">Figure 3
<p>GE increases the amount of fatty acids in vitro. hPKs were treated with 200 µg/mL GE for 6 days, and the lipid fraction was isolated and analyzed by GC-FID. The results were shown in a scatter blot (left graph), and in an untreated versus treated graph that shows the individual treatment effect within cells of the same skin biopsy (right graph). The <span class="html-italic">p</span> value is indicated in the figure by an asterisk (* <span class="html-italic">p</span> &lt; 0.05).</p>
Full article ">Figure 4
<p>GE-induced lipid synthesis involves the MAPK and PPAR pathway. hPKs were cultured in 96 well plates and were treated with vehicle, GE (200 µg/mL), or with GE and one of the inhibitors (p38 MAPK inhibitor SB203580, PPARγ antagonist GW9962; NFκB inhibitor GIV 3727, phosphatidyl-inositol-3-kinase inhibitor LY294002 or ERK inhibitor PD98059) for 6 days. (<b>A</b>) Quantitative measurement of intracellular neutral lipids as assessed after Nile Red labeling and (<b>B</b>) measurement of cell viability as was assessed with the ViaLight Plus bioassay kit. All Data are expressed as means ± SD of 6 independent experiments with 8 replicates respectively (ns—not significant, ** <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 5
<p>GE induces CerS3 expression but not sphingomyelinase activity. (<b>A</b>) hPKs were treated with GE (200 µg/mL) for 0, 2, or 6 days. Then, the cells were stained against CerS3. The pictures were photographed at magnification of 100×, and the bar indicates 50 µm; (<b>B</b>) hPKs were treated with GE (200 µg/mL), or with GE and one of the inhibitors (PPARγ antagonist GW9962 or p38 MAPK inhibitor SB203580) for 6 days. Then, the cells were stained against CerS3. The pictures were photographed at a magnification of 400×, and the bar indicates 10 µm; (<b>C</b>) hPKs were treated with GE (200 µg/mL) or with GE and inhibitors, as indicated, for 6 days. Then, the sphingomyelinase activity was measured in the cell lysates. Data are expressed as means ± SD of three independent experiments (ns—not significant).</p>
Full article ">Figure 6
<p>GE increases lipid synthesis in vivo. In a placebo controlled half side comparison, 33 adult volunteers were treated on their volar forearms with 5% GE cream, or placebo cream. The box blots show the lipid content of the skin after 2 weeks. The red, green and blue dots and squares correspond to one volunteer respectively. The arrows show the difference in the lipid content between the placebo and GE-treated forearm. The <span class="html-italic">p</span> value is indicated in the figures by asterisks (** <span class="html-italic">p</span> &lt; 0.01).</p>
Full article ">Figure 7
<p>HPLC-UV chromatogram of yellow gentian root CO<sub>2</sub>-extract. The detection was at 232 nm: peak identifications (concentrations) are: loganic acid (3.1%), swertiamarin (0.79%), gentiopicroside (12.3%), loganin (0.41%), and amarogentin (0.05%).</p>
Full article ">Figure 8
<p>The graph shows a representative GC-FID chromatogram of fatty acids GC-FID chromatogram of fatty acids extracted from the cell lipids. The first two peaks between 13 and 14 min retention time are C16:0 and C16:1n7 acids. The second group between 16 and 17 min are C18:0, C18:1n9, and C18:1n7 (shoulder) acids, and the smaller peak at 17.5 min is C18:2n6 acid. The red line indicates the base for peak integration.</p>
Full article ">
1063 KiB  
Review
Towards a Better Understanding of GABAergic Remodeling in Alzheimer’s Disease
by Karan Govindpani, Beatriz Calvo-Flores Guzmán, Chitra Vinnakota, Henry J. Waldvogel, Richard L. Faull and Andrea Kwakowsky
Int. J. Mol. Sci. 2017, 18(8), 1813; https://doi.org/10.3390/ijms18081813 - 21 Aug 2017
Cited by 143 | Viewed by 13142
Abstract
γ-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the vertebrate brain. In the past, there has been a major research drive focused on the dysfunction of the glutamatergic and cholinergic neurotransmitter systems in Alzheimer’s disease (AD). However, there is now growing evidence [...] Read more.
γ-aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the vertebrate brain. In the past, there has been a major research drive focused on the dysfunction of the glutamatergic and cholinergic neurotransmitter systems in Alzheimer’s disease (AD). However, there is now growing evidence in support of a GABAergic contribution to the pathogenesis of this neurodegenerative disease. Previous studies paint a complex, convoluted and often inconsistent picture of AD-associated GABAergic remodeling. Given the importance of the GABAergic system in neuronal function and homeostasis, in the maintenance of the excitatory/inhibitory balance, and in the processes of learning and memory, such changes in GABAergic function could be an important factor in both early and later stages of AD pathogenesis. Given the limited scope of currently available therapies in modifying the course of the disease, a better understanding of GABAergic remodeling in AD could open up innovative and novel therapeutic opportunities. Full article
(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
Show Figures

Figure 1

Figure 1
<p>An overview of the γ-aminobutyric acid (GABA) signaling system. The schematic diagram represents a GABAergic synapse and depicts the key aspects of GABAergic signal transduction. GABA is synthesized in the pre-synaptic terminal from glutamate by glutamic acid decarboxylase (GAD). GABA is then recruited into synaptic vesicles via the action of vesicular GABA transporter (vGAT). Following membrane depolarization, GABA is released into the synapse and can bind to either ionotropic GABA<sub>A</sub> receptors (GABA<sub>A</sub>R) or metabotropic GABA<sub>B</sub> receptors (GABA<sub>B</sub>R) on the postsynaptic membrane, resulting in inhibition of the post-synaptic neuron. Released GABA is cleared from the synapse by membrane-bound GABA transporters (GATs), localized to neurons and astrocytes. In astrocytes, GABA is recycled into synaptic vesicles or taken up by mitochondria, where it is metabolized by GABA transaminase (GABA-T) to glutamine for neuronal uptake.</p>
Full article ">
1706 KiB  
Review
Regulation of Mitochondrial Structure and Dynamics by the Cytoskeleton and Mechanical Factors
by Erzsébet Bartolák-Suki, Jasmin Imsirovic, Yuichiro Nishibori, Ramaswamy Krishnan and Béla Suki
Int. J. Mol. Sci. 2017, 18(8), 1812; https://doi.org/10.3390/ijms18081812 - 21 Aug 2017
Cited by 120 | Viewed by 15289
Abstract
Mitochondria supply cells with energy in the form of ATP, guide apoptosis, and contribute to calcium buffering and reactive oxygen species production. To support these diverse functions, mitochondria form an extensive network with smaller clusters that are able to move along microtubules aided [...] Read more.
Mitochondria supply cells with energy in the form of ATP, guide apoptosis, and contribute to calcium buffering and reactive oxygen species production. To support these diverse functions, mitochondria form an extensive network with smaller clusters that are able to move along microtubules aided by motor proteins. Mitochondria are also associated with the actin network, which is involved in cellular responses to various mechanical factors. In this review, we discuss mitochondrial structure and function in relation to the cytoskeleton and various mechanical factors influencing cell functions. We first summarize the morphological features of mitochondria with an emphasis on fission and fusion as well as how network properties govern function. We then review the relationship between the mitochondria and the cytoskeletal structures, including mechanical interactions. We also discuss how stretch and its dynamic pattern affect mitochondrial structure and function. Finally, we present preliminary data on how extracellular matrix stiffness influences mitochondrial morphology and ATP generation. We conclude by discussing the more general role that mitochondria may play in mechanobiology and how the mechanosensitivity of mitochondria may contribute to the development of several diseases and aging. Full article
(This article belongs to the Special Issue Mitochondria Crosstalks with other Organelles in Pathophysiology)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>The mitochondria are the powerhouses of the cell. Left: A cartoon of a mitochondrion showing its outer and inner membranes, the cristae, and the matrix. Fat and sugar enter the mitochondria through channels of the outer membrane. Right: The Krebs, or citric acid, cycle feeds the chain of respiratory complexes I through IV which create an electrical and proton (H<sup>+</sup>) gradient, the electromotive force across the inner membrane. ATP synthase utilizes the electromotive force to generate ATP from ADP and inorganic phosphate (P<sub>i</sub>) (Right image from Wikipedia [<a href="#B24-ijms-18-01812" class="html-bibr">24</a>]).</p>
Full article ">Figure 2
<p>Intracellular and extracellular processes contributing to mitochondrial structure and function. Intracellular mitochondrial (orange) dynamics include the processes of fusion, fission, mitophagy, and biogenesis. See text for explanation for how the various molecules such as OPA1, Mfn1, Mfn2, and DRP1 govern these processes. The grey mitochondrion is damaged and degraded by mitophagy. Green lines represent microtubules, along which small mitochondrial clusters can travel with the aid of motor proteins. The dashed line represents the site of fission and the red arrows indicate the cyclic nature of fission and fusion. Note that biogenesis increases mitochondrial volume and is regulated by the peroxisome proliferator-activated receptor γ coactivator (PGC-1α). Cells are connected to the ECM (extracellular matrix) and exposed to external mechanical forces (F) at focal adhesions (FA), involving integrin receptors (Int) on the cell surface and Arg-Gly-Asp (RGD) binding sites on collagens fibers (Col-I). The cytoskeleton is linked to FAs and therefore mechanical forces from the ECM are transmitted to the mitochondria.</p>
Full article ">Figure 3
<p>Cells were cultured on elastic membranes that could be stretched equibiaxially in a stretching device. (<b>A</b>) A cell labeled for cytosol (green), mitochondria (red: tetramethylrhodamine methyl ester, TMRM), and nucleus (blue) at 0% (left) and 14% (right) strains. (<b>B</b>) The top row shows the mitochondrial network of an entire cell imaged during constant strain application at increments of 0, 7, 14, and 30% change in membrane surface area. The bottom row shows the zoomed-in details of an individual cluster (green rectangle in top row) changing shape as higher strains are applied (green arrow), as well as a cluster undergoing fission and splitting into two smaller clusters (red arrow) [<a href="#B77-ijms-18-01812" class="html-bibr">77</a>].</p>
Full article ">Figure 4
<p>Relationship between complexity, measured by the fractal dimension D<sub>f</sub>, and function, assessed by a fluorescent dye (TMRM, see text) intensity that is related to ATP production rate in VSMCs. There is a linear relation between the log of ATP production and D<sub>f</sub>. The dots represent binned data from about 2000 cells showing unstretched control cells (US), 4 h of monotonously stretched (MS) cells (10% area strain at 1 Hz), and 4 h of stretching cells with a variable stretch (VS) pattern in which every cycle is different with the amplitudes uniformly distributed between 7.5% and 12.5% area strain. The US cells are in the lower left corner. These cells produce little energy and their mitochondrial fractal organization is the least complex. MS cells produce somewhat more energy and their D<sub>f</sub> is also higher, whereas VS cells produce the most ATP and have the highest complexity in terms of their fractal organization. The images show mitochondrial networks corresponding to US, MS, and VS cells. ATP production rate is related to the intensity of red color. The results were obtained by reanalyzing the data from [<a href="#B14-ijms-18-01812" class="html-bibr">14</a>].</p>
Full article ">Figure 5
<p>Mitochondrial structure-function relations as a function of substrate stiffness. VSMCs were seeded on substrates of different stiffness, labeled with TMRM, and cluster sizes and mean intensities were measured. The horizontal lines in the boxes are the median, the box represents the 25th percentile, and the horizontal bars are the 75th percentile of the data. The symbols are data outside the 75th percentile. (<b>A</b>) Cluster sizes were stiffness dependent, but only the clusters on 12.5 kPa stiffness were different from the rest. (<b>B</b>) Intensities were also stiffness dependent, and again only data on 12.5 kPa stiffness were different from the rest.</p>
Full article ">
1673 KiB  
Article
NPFFR2 Activates the HPA Axis and Induces Anxiogenic Effects in Rodents
by Ya-Tin Lin, Yu-Lian Yu, Wei-Chen Hong, Ting-Shiuan Yeh, Ting-Chun Chen and Jin-Chung Chen
Int. J. Mol. Sci. 2017, 18(8), 1810; https://doi.org/10.3390/ijms18081810 - 21 Aug 2017
Cited by 23 | Viewed by 11769
Abstract
Neuropeptide FF (NPFF) belongs to the RFamide family and is known as a morphine-modulating peptide. NPFF regulates various hypothalamic functions through two receptors, NPFFR1 and NPFFR2. The hypothalamic-pituitary-adrenal (HPA) axis participates in physiological stress response by increasing circulating glucocorticoid levels and modulating emotional [...] Read more.
Neuropeptide FF (NPFF) belongs to the RFamide family and is known as a morphine-modulating peptide. NPFF regulates various hypothalamic functions through two receptors, NPFFR1 and NPFFR2. The hypothalamic-pituitary-adrenal (HPA) axis participates in physiological stress response by increasing circulating glucocorticoid levels and modulating emotional responses. Other RFamide peptides, including neuropeptide AF, neuropeptide SF and RFamide related peptide also target NPFFR1 or NPFFR2, and have been reported to activate the HPA axis and induce anxiety- or depression-like behaviors. However, little is known about the action of NPFF on HPA axis activity and anxiety-like behaviors, and the role of the individual receptors remains unclear. In this study, NPFFR2 agonists were used to examine the role of NPFFR2 in activating the HPA axis in rodents. Administration of NPFFR2 agonists, dNPA (intracerebroventricular, ICV) and AC-263093 (intraperitoneal, IP), time-dependently (in rats) and dose-dependently (in mice) increased serum corticosteroid levels and the effects were counteracted by the NPFF receptor antagonist, RF9 (ICV), as well as corticotropin-releasing factor (CRF) antagonist, α-helical CRF(9-41) (intravenous, IV). Treatment with NPFFR2 agonist (AC-263093, IP) increased c-Fos protein expression in the hypothalamic paraventricular nucleus and induced an anxiogenic effect, which was evaluated in mice using an elevated plus maze. These findings reveal, for the first time, that the direct action of hypothalamic NPFFR2 stimulates the HPA axis and triggers anxiety-like behaviors. Full article
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Effect of AC-263093 on the hypothalamic-pituitary-adrenal (HPA) axis in mice. Mice were intraperitoneal (IP) injected with vehicle or AC-263093 (5, 7.5, 10, 20, 30 mg/kg) and sacrificed after 1 h. Levels of serum corticosteroid (CORT) were measured by ELISA. Data are expressed as mean ± standard error of the mean (SEM) and were analyzed using a one-way ANOVA followed by Newman-Keuls post hoc tests. *, <span class="html-italic">p</span> &lt; 0.05; ***, <span class="html-italic">p</span> &lt; 0.001, compared to vehicle controls (<span class="html-italic">n</span> = 5 per group).</p>
Full article ">Figure 2
<p>Time-dependent effects of treatment with dNPA on serum CORT in rats. Rats were injected with vehicle or dNPA (10 nmol, intracerebroventricular, ICV) and serum CORT was monitored up to 70 min following injection. (<b>A</b>) Levels of serum CORT were measured to indicate the activity of the HPA axis. Neuropeptide FF (NPFF) receptor antagonist RF9 (10 nmol, ICV) was administered 15 min prior to dNPA treatment. Data are expressed as mean ± SEM and were analyzed using a two-way ANOVA following by Bonferroni post hoc tests. * <span class="html-italic">p</span> &lt; 0.05, compared dNPA to vehicle controls. # <span class="html-italic">p</span> &lt; 0.05; ## <span class="html-italic">p</span> &lt; 0.01, compared dNPA to RF9+dNPA group; (<b>B</b>) The results of area under curve (AUC) calculation. Data are expressed as mean ± SEM and were analyzed using a one-way ANOVA following by Bonferroni post hoc tests. * <span class="html-italic">p</span> &lt; 0.05, compared dNPA to vehicle controls (<span class="html-italic">n</span> = 4–7 per group).</p>
Full article ">Figure 3
<p>Time-dependent effects of treatment with AC-263093 on serum CORT in rats. Rats were injected with vehicle or AC-263093 (30 mg/kg, IP) and serum CORT was monitored for up to 90 min post-administration. (<b>A</b>) Levels of serum CORT were measured by ELISA. Corticotropin-releasing factor (CRF) antagonist α-helical CRF(9-41) (200 μg, intravenous, IV) was applied 15 min prior to AC-263093 treatment. Data are expressed as mean ± SEM and analyzed using a two-way ANOVA following by Bonferroni post hoc tests. * <span class="html-italic">p</span> &lt; 0.05, compared AC-263093 to vehicle controls; (<b>B</b>) The results of AUC calculation. Data are expressed as mean ± SEM and were analyzed using a one-way ANOVA following by Bonferroni post hoc tests. * <span class="html-italic">p</span> &lt; 0.05, compared dNPA to vehicle controls (<span class="html-italic">n</span> = 4–11 per group).</p>
Full article ">Figure 4
<p>Effects of AC-263093 treatment on c-Fos expression in paraventricular nucleus (PVN) neurons. Mice were injected with vehicle or AC-263093 (30 mg/kg, IP) and sacrificed after 1 h. (<b>A</b>) Immunofluorescence staining was used to detect c-Fos expression in the PVN. Nuclei were counterstained with DAPI; (<b>B</b>) Quantification of c-Fos-positive cell numbers in the PVN. Histogram B shows the c-Fos immunoreactive neurons counts expressed as sum of bilateral frontal cross section surface areas of PVN. Data are expressed as mean ± SEM and were analyzed using an unpaired Student’s <span class="html-italic">t</span>-test. **, <span class="html-italic">p</span> &lt; 0.01, compared to vehicle control (<span class="html-italic">n</span> = 4 per group). Scale bar = 100 μm.</p>
Full article ">Figure 5
<p>Effects of AC-263093 treatment on anxiety-like behavior. Mice were injected with AC-263093 (30 mg/kg, IP) 1 h prior to behavioral testing. Anxiety-like behavior was evaluated by the elevated plus maze (EPM). (<b>A</b>) Time that mice stayed in the open arms or closed arms; (<b>B</b>) Number of entries into open arms; (<b>C</b>) Total time spent with movement. Data are expressed as mean ± SEM and were analyzed using an unpaired Student’s <span class="html-italic">t</span>-test. *, <span class="html-italic">p</span> &lt; 0.05; **, <span class="html-italic">p</span> &lt; 0.01, compared to vehicle controls (<span class="html-italic">n</span> = 7–8 per group).</p>
Full article ">
2020 KiB  
Article
Protocatechuic Acid from Pear Inhibits Melanogenesis in Melanoma Cells
by Xuan T. Truong, Seo-Hee Park, Yu-Geon Lee, Hang Yeon Jeong, Jae-Hak Moon and Tae-Il Jeon
Int. J. Mol. Sci. 2017, 18(8), 1809; https://doi.org/10.3390/ijms18081809 - 21 Aug 2017
Cited by 36 | Viewed by 12020
Abstract
Despite the critical role of melanin in the protection of skin against UV radiation, excess production of melanin can lead to hyperpigmentation and skin cancer. Pear fruits are often used in traditional medicine for the treatment of melasma; therefore, we investigated the effects [...] Read more.
Despite the critical role of melanin in the protection of skin against UV radiation, excess production of melanin can lead to hyperpigmentation and skin cancer. Pear fruits are often used in traditional medicine for the treatment of melasma; therefore, we investigated the effects of pear extract (PE) and its component, protocatechuic acid (PCA), on melanogenesis in mouse melanoma cells. We found that PE and PCA significantly suppressed melanin content and cellular tyrosinase activity through a decrease in the expression of melanogenic enzymes and microphthalmia-associated transcription factor (Mitf) in α-melanocyte stimulating hormone-stimulated mouse melanoma cells. Moreover, PCA decreased cyclic adenosine monophosphate (cAMP) levels and cAMP-responsive element-binding protein phosphorylation, which downregulated Mitf promoter activation and subsequently mediated the inhibition of melanogenesis. These results suggested that pear may be an effective skin lightening agent that targets either a tyrosinase activity or a melanogenic pathway. Full article
(This article belongs to the Special Issue Melanins and Melanogenesis: From Nature to Applications)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Effects of pear extract (PE) on melanogenesis in mouse melanoma cells. (<b>a</b>) B16F10 cells were treated with various concentrations of PE for 72 h. The cell viability was measured by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. * <span class="html-italic">p</span> &lt; 0.05 vs. control dimethyl sulfoxide (DMSO); (<b>b</b>) Cells were exposed to 1 μM α-melanocyte stimulating hormone (α-MSH) in presence or absence of PE (mg/mL) or 2 mM arbutin (Ar) for 72 h. Cell pellet images were taken using a digital camera and melanin contents were measured with synthetic melanin as standard. * <span class="html-italic">p</span> &lt; 0.05 vs. control; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. α-MSH; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. α-MSH; (<b>c</b>) Mushroom tyrosinase activity in the absence or presence of PE (0.5 mg/mL) or arbutin (2 mM). * <span class="html-italic">p</span> &lt; 0.05 vs. DMSO; ** <span class="html-italic">p</span> &lt; 0.01 vs. DMSO.</p>
Full article ">Figure 2
<p>Effects of PE on expression of melanogenic genes. B16F10 cells were exposed to α-MSH in presence or absence of PE (mg/mL) for 24 h. (<b>a</b>) mRNA levels for <span class="html-italic">Mitf-M</span>, <span class="html-italic">Tyr</span>, <span class="html-italic">Trp1</span>, and <span class="html-italic">Trp2</span> were analyzed by RT-qPCR. * <span class="html-italic">p</span> &lt; 0.05 vs. control; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. α-MSH; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. α-MSH; <sup>###</sup> <span class="html-italic">p</span> &lt; 0.001 vs. α-MSH. Data are mean ± SEM; <span class="html-italic">n</span> = 3; (<b>b</b>) Cell lysates were analyzed for microphthalmia-associated transcription factor (MITF), tyrosinase (TYR), tyrosinase-related protein 1 (TRP1), and tyrosinase-related protein 2 (TRP2) protein levels by immunoblotting.</p>
Full article ">Figure 3
<p>Effects of protocatechuic acid (PCA) on melanin synthesis and tyrosinase activity. (<b>a</b>) Structure of PCA; (<b>b</b>) B16F10 cells were treated with various concentrations of PCA for 72 h. The cell viability was measured by MTT assay; (<b>c</b>) Cells were exposed to 1 μM α-MSH in presence or absence of PCA (μM) for 72 h. Melanin contents were measured with synthetic melanin as standard. * <span class="html-italic">p</span> &lt; 0.05 vs. control; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. α-MSH; (<b>d</b>) Cells were exposed to 1 μM α-MSH in presence or absence of PCA (μM) for 24 h. Cellular tyrosinase activity. * <span class="html-italic">p</span> &lt; 0.05 vs. control; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. α-MSH; (<b>e</b>) Mushroom tyrosinase activity in a cell free system. Data are mean ± SEM; <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 4
<p>Effects of PCA on expression of melanogenic genes and activation of MITF promoter. B16F10 cells were exposed to α-MSH in presence or absence of PCA (μM) for 24 h. (<b>a</b>) mRNA levels for <span class="html-italic">Mitf-M</span>, <span class="html-italic">Tyr</span>, <span class="html-italic">Trp1</span>, and <span class="html-italic">Trp2</span> were analyzed by RT-qPCR. * <span class="html-italic">p</span> &lt; 0.05 vs. control; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. α-MSH. Data are mean ± SEM; <span class="html-italic">n</span> = 3; (<b>b</b>) Cell lysates were analyzed for MITF, TYR, TRP1, and TRP2 protein levels by immunoblotting; (<b>c</b>) Reporter assays were performed using mouse MITF-M promoter construct. Cells were transfected with wild type (wt) cAMP-responsive element (CRE) or mtCRE luciferase reporters for 24 h before treatment with PCA (μM) and/or α-MSH for 24 h. * <span class="html-italic">p</span> &lt; 0.05 vs. control; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. α-MSH; <sup>##</sup> <span class="html-italic">p</span> &lt; 0.01 vs. α-MSH; <sup>###</sup> <span class="html-italic">p</span> &lt; 0.005 vs. α-MSH. Data are mean ± SEM; <span class="html-italic">n</span> = 3.</p>
Full article ">Figure 5
<p>Effects of PCA on CREB phosphorylation and intracellular cAMP level. B16F10 cells were pretreated with 100 μM PCA for 24 h prior to 1 μM α-MSH treatment for indicated time. (<b>a</b>) Cell lysates were analyzed for pCREB, CREB, and GAPDH protein levels by immunoblotting; (<b>b</b>) mRNA levels for <span class="html-italic">Pgc-1α</span> were analyzed by RT-qPCR. * <span class="html-italic">p</span> &lt; 0.05 vs. control; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. α-MSH; (<b>c</b>) Cells were pretreated with 100 μM PCA for 24 h, and then exposed to 1 μM α-MSH for 30 min. Intracellular cAMP concentration was measured by immunoassay as described in Materials and methods. * <span class="html-italic">p</span> &lt; 0.05 vs. control; <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. α-MSH; (<b>d</b>) Cells were exposed to 20 μM forskolin (Fsk) or 100 μM 8-Br-cAMP in presence or absence of PCA (100 μM) for 24 h. mRNA levels for <span class="html-italic">Mitf-M</span> and <span class="html-italic">Pgc-1α</span>. <sup>#</sup> <span class="html-italic">p</span> &lt; 0.05 vs. Fsk; ns, not significant. Data are mean ± SEM; <span class="html-italic">n</span> = 3; (<b>e</b>) Protein level for MITF.</p>
Full article ">Figure 6
<p>A proposed mechanism for inhibitory effect of PE and its components (PCA and arbutin) on melanogenesis. Arrows indicate positive regulation while T-bars denote inhibitory effects.</p>
Full article ">
6318 KiB  
Article
Muscle Conditional Medium Reduces Intramuscular Adipocyte Differentiation and Lipid Accumulation through Regulating Insulin Signaling
by Haiyin Han, Wei Wei, Weiwei Chu, Kaiqing Liu, Ye Tian, Zaohang Jiang and Jie Chen
Int. J. Mol. Sci. 2017, 18(8), 1799; https://doi.org/10.3390/ijms18081799 - 20 Aug 2017
Cited by 14 | Viewed by 6375
Abstract
Due to the paracrine effects of skeletal muscle, the lipid metabolism of porcine intramuscular (i.m.) preadipocytes was different from that of subcutaneous (s.c.) preadipocytes. To investigate the development of i.m. preadipocytes in vivo, the s.c. preadipocytes were cultured with muscle conditional cultured medium [...] Read more.
Due to the paracrine effects of skeletal muscle, the lipid metabolism of porcine intramuscular (i.m.) preadipocytes was different from that of subcutaneous (s.c.) preadipocytes. To investigate the development of i.m. preadipocytes in vivo, the s.c. preadipocytes were cultured with muscle conditional cultured medium (MCM) for approximating extracellular micro-environment of the i.m. preadipocytes. Insulin signaling plays a fundamental role in porcine adipocyte differentiation. The expression levels of insulin receptor (INSR) and insulin-like growth factor 1 receptor (IGF-1R) in i.m. Preadipocytes were higher than that in s.c. preadipocytes. The effects of MCM on adipocyte differentiation, lipid metabolism and insulin signaling transdution were verified. MCM induced the apoptosis of s.c. preadipocytes but not of s.c. adipocytes. Moreover, MCM inhibited adipocyte differentiation at pre-differentiation and early stages of differentiation, while the expression levels of INSR and IGF-1R were increased. Furthermore, MCM treatment increased adipocyte lipolysis and fatty acid oxidation through induction of genes involved in lipolysis, thermogenesis, and fatty acid oxidation in mitochondria. Consistent with the above, treatment of s.c. adipocytes with MCM upregulated mitochondrial biogenesis. Taken together, MCM can approximate the muscle micro-environment and reduce intramuscular adipocyte differentiation and lipid accumulation via regulating insulin signaling. Full article
(This article belongs to the Special Issue Adipose Stem Cells)
Show Figures

Figure 1

Figure 1
<p>Identification of porcine i.m. and s.c. preadipocytes. The dedifferentiated porcine intramuscular (i.m.) and subcutaneous (s.c.) preadipocytes showed fibroblast-like morphology (<b>A</b>); The i.m. and s.c. preadipocytes were induced in adipogenic medium at confluence. Nine days later, the i.m. and s.c. preadipocytes were re-differentiated to mature adipocytes with lipid droplets (<b>B</b>); The isolated i.m. and s.c. preadipocytes were seeded in 12-well plates, and the cells of day 3 were detected by Pref-1 immunofluorescent staining (<b>C</b>). Scale bar = 100 μm.</p>
Full article ">Figure 2
<p>Downregulation of insulin receptor (<span class="html-italic">INSR</span>) or IGF-1 receptor (<span class="html-italic">IGF-1R</span>) by siRNA interference decreased porcine adipocyte differentiation. The siRNAs targeting INSR and IGF-1R (si-INSR, si-IGF-1R) were transfected into porcine s.c. preadipocytes. The <span class="html-italic">INSR</span>/<span class="html-italic">IGF-1R</span> mRNA (<b>A</b>) (<span class="html-italic">n</span> = 6) and protein levels (<b>B</b>) (<span class="html-italic">n</span> = 3) were verified after transfected with siNC and si-INSR/si-IGF-1R at 24 and 48 h, respectively; Transfected s.c. preadipocytes were induced to differentiate for nine days; The intracellular accumulation was determined by cytoplasm triglyceride content (<b>C</b>) (<span class="html-italic">n</span> = 4) and Oil Red O staining (<b>D</b>) (<span class="html-italic">n</span> = 3). The mRNA expression differences were normalized to Ribosomal protein lateral stalk subunit P0 (<span class="html-italic">RPLP0</span>) mRNA level. The β-actin bands served as an internal control for protein loading. ** <span class="html-italic">p</span> &lt; 0.01, Scale bar = 200 μm.</p>
Full article ">Figure 3
<p><span class="html-italic">INSR</span> and <span class="html-italic">IGF-1R</span> expression pattern in i.m. and s.c. preadipocytes. The comparison of <span class="html-italic">INSR</span> and <span class="html-italic">IGF-1R</span> mRNA expression levels in i.m. and s.c. preadipocytes (<b>A</b>) (<span class="html-italic">n</span> = 3); The protein expression level of <span class="html-italic">IGF-1R</span> in i.m. and s.c. preadipocytes was detected by Western blot and subsequently quantified. (<b>B</b>) (<span class="html-italic">n</span> = 3). The mRNA expression differences were normalized to <span class="html-italic">RPLP0</span> mRNA level. The β-actin bands served as an internal control for protein loading. ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 4
<p>The inhibitory effect of muscle conditional medium (MCM) on s.c. preadipocytes differentiation. Confluenced s.c. preadipocytes were incubated in adipogenic medium supplemented with an increasing amount of MCM at the indicated total protein concentration (<span class="html-italic">n</span> = 3). After nine days, adipocytes were staining with Oil Red O. Scale bar = 200 μm.</p>
Full article ">Figure 5
<p>Flow cytometric detection and quantification of MCM-induced apoptosis in porcine s.c. preadipocytes and s.c. adipocytes. Porcine s.c. preadipocytes (<b>A</b>) and s.c. adipocytes (<b>B</b>) were cultured for three days with MCM versus physiological saline, and stained with fluorescein isothiocyanate (FITC)-labled annexin V (Annexin V-FITC) and propidium iodine (PI); then, the cell apoptosis was analyzed. <span class="html-italic">n</span> = 3, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, Scale bar = 200 μm.</p>
Full article ">Figure 6
<p>The effective duration of activity of MCM during adipocyte differentiation. s.c. preadipocytes were treated for three days with MCM at 120 μg mL<sup>−1</sup> total protein concentration for four different time intervals: pre-differentiation (day –3 to 0), early (day 0 to 3), middle (day 4 to 6), and late (day 7 to 9) stages of differentiation. After nine days of differentiation, the effects of MCM on intracellular oil droplets (<b>A</b>) (<span class="html-italic">n</span> = 3), triglycerides content (<b>B</b>) (<span class="html-italic">n</span> = 3) and peroxisome proliferator-activated receptor γ (<span class="html-italic">PPARγ</span>) and fatty acid binding protein (<span class="html-italic">FABP4</span>) mRNA expression (<b>C</b>) (<span class="html-italic">n</span> = 6) were verified. The mRNA expression differences were normalized to <span class="html-italic">RPLP0</span> mRNA levels. Triglyceride content was normalized to protein content. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, Scale bar = 200 μm.</p>
Full article ">Figure 7
<p>The genes expression patterns in the <span class="html-italic">INSR</span>/<span class="html-italic">IGF-1R</span>-<span class="html-italic">IRS-1</span> signaling. The mRNA expression of <span class="html-italic">INSR</span>, <span class="html-italic">IGF-1R</span> and <span class="html-italic">IRS-1</span> with MCM treatment at the pre-differentiation stage of adipocyte differentiation for three days (<b>A</b>) (<span class="html-italic">n</span> = 4); The protein abundance of <span class="html-italic">IGF-1R</span>, <span class="html-italic">IRS-1</span>, and <span class="html-italic">p-IRS-1</span> with MCM treatment at pre-differentiation stage for three days (<b>B</b>) and protein quantified was shown (<b>C</b>) (<span class="html-italic">n</span> = 3 for control, <span class="html-italic">n</span> = 4 for treatment); The mRNA expression of <span class="html-italic">INSR</span> (<b>D</b>) (<span class="html-italic">n</span> = 6), <span class="html-italic">IGF-1R</span> ((<b>E</b>) <span class="html-italic">n</span> = 6), and <span class="html-italic">IRS-1</span> ((<b>F</b>) <span class="html-italic">n</span> = 6) with MCM treatment for different durations; The protein abundance of <span class="html-italic">IGF-1R</span>, <span class="html-italic">IRS-1</span>, and <span class="html-italic">p-IRS-1</span> with MCM treatment during different differentiation durations (<b>G</b>) and protein quantified was shown ((<b>H</b>) <span class="html-italic">n</span> = 3); The mRNA expression differences were normalized to <span class="html-italic">RPLP0</span> mRNA level. The β-actin bands served as an internal control for protein loading, <span class="html-italic">p-IRS-1</span> (Try) expression was normalized to <span class="html-italic">IRS-1</span> expression. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">Figure 8
<p>Effect of MCM on adipocyte lipolysis and fatty acid oxidation. Fully differentiated adipocytes were incubated with the Dulbecco’s Modified Eagle’s medium (DMEM) (no phenol red) with MCM for 24 h to verify the lipolytic effects of MCM. The glycerol levels in the culture medium were assayed (<b>A</b>); Adipocytes were cultured with MCM for three days. The expression levels of genes involved in lipolysis (<span class="html-italic">ATGL</span> and <span class="html-italic">HSL</span>) and fatty acid synthesis (<span class="html-italic">FASN</span> and <span class="html-italic">ACC</span>) (<b>B</b>) were detected by q PCR, respectively; Relative mRNA expression of genes responsible for fatty acid oxidation (<span class="html-italic">PPARα</span>, <span class="html-italic">Cpt-1α</span>, and <span class="html-italic">Cpt-1β</span>) (<b>C</b>) and thermogenesis (<span class="html-italic">PGC-1α</span>, <span class="html-italic">PRDM16</span>, and <span class="html-italic">Cidea</span>) (<b>D</b>) was detected; Relative abundance of mitochondrial DNA (mtDNA) (<b>E</b>) and the genes responsible for mitochondrial biogenesis (<span class="html-italic">PGC-1α</span>, <span class="html-italic">TRFM</span>, and <span class="html-italic">NRF</span>) (<b>F</b>) were detected. Dates were normalized to the mRNA levels of <span class="html-italic">RPLP0</span>. <span class="html-italic">n</span> = 6, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01.</p>
Full article ">
891 KiB  
Review
Crosstalk between DNA Damage and Inflammation in the Multiple Steps of Carcinogenesis
by Shosuke Kawanishi, Shiho Ohnishi, Ning Ma, Yusuke Hiraku and Mariko Murata
Int. J. Mol. Sci. 2017, 18(8), 1808; https://doi.org/10.3390/ijms18081808 - 19 Aug 2017
Cited by 188 | Viewed by 11722
Abstract
Inflammation can be induced by chronic infection, inflammatory diseases and physicochemical factors. Chronic inflammation is estimated to contribute to approximately 25% of human cancers. Under inflammatory conditions, inflammatory and epithelial cells release reactive oxygen (ROS) and nitrogen species (RNS), which are capable of [...] Read more.
Inflammation can be induced by chronic infection, inflammatory diseases and physicochemical factors. Chronic inflammation is estimated to contribute to approximately 25% of human cancers. Under inflammatory conditions, inflammatory and epithelial cells release reactive oxygen (ROS) and nitrogen species (RNS), which are capable of causing DNA damage, including the formation of 8-oxo-7,8-dihydro-2′-deoxyguanosine and 8-nitroguanine. We reported that 8-nitroguanine was clearly formed at the sites of cancer induced by infectious agents including Helicobacter pylori, inflammatory diseases including Barrett’s esophagus, and physicochemical factors including asbestos. DNA damage can lead to mutations and genomic instability if not properly repaired. Moreover, DNA damage response can also induce high mobility group box 1-generating inflammatory microenvironment, which is characterized by hypoxia. Hypoxia induces hypoxia-inducible factor and inducible nitric oxide synthase (iNOS), which increases the levels of intracellular RNS and ROS, resulting DNA damage in progression with poor prognosis. Furthermore, tumor-producing inflammation can induce nuclear factor-κB, resulting in iNOS-dependent DNA damage. Therefore, crosstalk between DNA damage and inflammation may play important roles in cancer development. A proposed mechanism for the crosstalk may explain why aspirin decreases the long-term risk of cancer mortality. Full article
(This article belongs to the Special Issue Mechanisms Leading to Genomic Instability)
Show Figures

Figure 1

Figure 1
<p>Mechanism for DNA damage in epithelial cells by inflammation. NO and O<sub>2</sub><sup>−</sup> are produced during inflammation. Although NO is sufficiently long-lived to diffuse through the extracellular matrix, and enter the nucleus, O<sub>2</sub><sup>−</sup> released by neutrophils or macrophages during inflammation is not sufficiently long-lived. Alternatively, inflammatory cells may use cytokines such as TNF-α to stimulate O<sub>2</sub><sup>−</sup> formation via Nox in neighboring epithelial cells. NO, which is generated by especially iNOS, reacts with O<sub>2</sub><sup>−</sup> forming ONOO<sup>−</sup>, which causes mutagenic DNA damage, such as 8-nitroguanine and 8-oxodG. NO and ROS can participate in inhibition of a number of DNA repair enzymes, which enhances mutations, leading to genomic instability.</p>
Full article ">Figure 2
<p>Mechanism for crosstalk between DNA damage and inflammation in the multiple steps of carcinogenesis. In cancer cells, cell death, which is induced by ROS and RNS, can induce HMGB1 expression. HMGB1 is passively released into the extracellular space from damaged or necrotic cells. Hypoxia induces HIF-1 expression, which regulates iNOS expression, and promotes translocation of HMGB1 from the nucleus to the cytoplasm. Via TLR4, extracellular HMGB1 can promote NF-κB transportation to the nucleus and induce the expression of TNF-α and IL-6, which induce iNOS expression. NO, which is generated by iNOS in tumor-associated macrophage (TAM), is released to the extracellular space and interacts with O<sub>2</sub><sup>−</sup> generated via Nox in cancer cells to form ONOO<sup>−</sup>. ONOO<sup>−</sup> causes DNA damage resulting in mutations and genomic instability as not properly repaired. NF-κB induces not only iNOS but also COX-2 expression. COX-2 participates in formation of PGE2, which induces iNOS. Aspirin can inhibit COX-2, resulting in the decrease of PGE2 and iNOS and suppression of the crosstalk between DNA damage and inflammation in cancer development. This is a possible mechanism by which aspirin reduces the long-term risk of death due to cancer.</p>
Full article ">
3009 KiB  
Article
Signaling Cascade Involved in Rapid Stimulation of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) by Dexamethasone
by Miriam Bossmann, Benjamin W. Ackermann, Ulrich H. Thome and Mandy Laube
Int. J. Mol. Sci. 2017, 18(8), 1807; https://doi.org/10.3390/ijms18081807 - 19 Aug 2017
Cited by 6 | Viewed by 6132
Abstract
Impairment of mucociliary clearance with reduced airway fluid secretion leads to chronically inflamed airways. Cystic fibrosis transmembrane conductance regulator (CFTR) is crucially involved in airway fluid secretion and dexamethasone (dexa) has previously been shown to elevate CFTR activity in airway epithelial cells. However, [...] Read more.
Impairment of mucociliary clearance with reduced airway fluid secretion leads to chronically inflamed airways. Cystic fibrosis transmembrane conductance regulator (CFTR) is crucially involved in airway fluid secretion and dexamethasone (dexa) has previously been shown to elevate CFTR activity in airway epithelial cells. However, the pathway by which dexa increases CFTR activity is largely unknown. We aimed to determine whether the increase of CFTR activity by dexa is achieved by non-genomic signaling and hypothesized that the phosphoinositide 3-kinase (PI3K) pathway is involved in CFTR stimulation. Primary rat airway epithelial cells and human bronchial submucosal gland-derived Calu-3 cells were analyzed in Ussing chambers and kinase activation was determined by Western blots. Results demonstrated a critical involvement of PI3K and protein kinase B (AKT) signaling in the dexa-induced increase of CFTR activity, while serum and glucocorticoid dependent kinase 1 (SGK1) activity was not essential. We further demonstrated a reduced neural precursor cell expressed, developmentally downregulated 4-like (NEDD4L) ubiquitin E3 ligase activity induced by dexa, possibly responsible for the elevated CFTR activity. Finally, increases of CFTR activity by dexa were demonstrated within 30 min accompanied by rapid activation of AKT. In conclusion, dexa induces a rapid stimulation of CFTR activity which depends on PI3K/AKT signaling in airway epithelial cells. Glucocorticoids might thus represent, in addition to their immunomodulatory actions, a therapeutic strategy to rapidly increase airway fluid secretion. Full article
(This article belongs to the Special Issue Physiological and Pathological Roles of ABC Transporters)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Phosphoinositide 3-kinase (PI3K) contributes to the increased cystic fibrosis transmembrane conductance regulator (CFTR) activity induced by dexa. Primary airway epithelial cells were treated with 100 nM dexa and LY-294002 (10 µM) for 24 h. Data bars represent mean + standard error of the mean (SEM) of I<sub>SC</sub>. Dexa increased the CFTR<sub>inh</sub>172-sensitive I<sub>SC</sub>. Addition of LY-294002 prevented the dexa-induced increase of CFTR activity (<span class="html-italic">n</span> = 20–25, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, analysis of variance (ANOVA) with Tukey’s <span class="html-italic">post hoc</span> test).</p>
Full article ">Figure 2
<p>Serum and glucocorticoid dependent kinase 1 activity is not involved in the dexa-stimulated CFTR activity. Cells were treated with 100 nM dexa and GSK650394 (10 µM) for 24 h. Data bars represent mean + SEM of I<sub>SC</sub>. (<b>a</b>) In primary airway epithelial cells, the CFTR<sub>inh</sub>172-sensitive I<sub>SC</sub> was increased by dexa. Addition of GSK650394 displayed no effect on the dexa-induced increase of CFTR activity (<span class="html-italic">n</span> = 10–15, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, ANOVA with Tukey’s <span class="html-italic">post hoc</span> test); (<b>b</b>) in Calu-3 cells CFTR<sub>inh</sub>172-sensitive I<sub>SC</sub> was increased by dexa. In agreement, GSK650394 displayed no effect on the dexa-induced increase of CFTR activity (<span class="html-italic">n</span> = 24–31, * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, ANOVA with Tukey’s <span class="html-italic">post hoc</span> test).</p>
Full article ">Figure 3
<p>SGK1 activity is elevated by dexa and reduced by GSK650394. (<b>a</b>) Normalized densitometric evaluation of n-myc downregulated gene 1 (NDRG1) and pNDRG1 Western blots. Calu-3 cells were treated with 100 nM dexa and GSK650394 (10 µM) or mifepristone (10 µM) for 24 h (<span class="html-italic">n</span> = 4; * <span class="html-italic">p</span> &lt; 0.05 by <span class="html-italic">t</span>-test); (<b>b</b>) western blot of pNDRG1 and total NDRG1 resulted in bands of 46 and 48 kDa.</p>
Full article ">Figure 4
<p>Akt1/2 kinase inhibitor prevents the increase of CFTR activity induced by dexa. Cells were treated with 100 nM dexa and Akt1/2 kinase inhibitor (10 µM) for 24 h. Data bars represent the mean + SEM of I<sub>SC</sub>. (<b>a</b>) In primary airway epithelial cells, the CFTR<sub>inh</sub>172-sensitive I<sub>SC</sub> was increased by dexa. Addition of Akt1/2 kinase inhibitor prevented the dexa-induced increase of CFTR activity (<span class="html-italic">n</span> = 11–14; *** <span class="html-italic">p</span> &lt; 0.001, ANOVA with Tukey’s <span class="html-italic">post hoc</span> test); (<b>b</b>) in Calu-3 cells the CFTR<sub>inh</sub>172-sensitive I<sub>SC</sub> was increased by dexa. Likewise, addition of Akt1/2 kinase inhibitor prevented the dexa-induced increase of CFTR activity (<span class="html-italic">n</span> = 36–37, *** <span class="html-italic">p</span> &lt; 0.001, ANOVA with Tukey’s <span class="html-italic">post hoc</span> test).</p>
Full article ">Figure 5
<p>AKT activity is elevated by dexa. (<b>a</b>) Normalized densitometric evaluation of pAKT and AKT Western blots. Calu-3 cells were treated with 100 nM dexa and Akt1/2 kinase inhibitor (10 µM) or mifepristone (10 µM) for 24 h. Addition of mifepristone and Akt1/2 kinase inhibitor blocked the increased AKT activity induced by dexa (<span class="html-italic">n</span> = 4; * <span class="html-italic">p</span> &lt; 0.05; *** <span class="html-italic">p</span> &lt; 0.001 by <span class="html-italic">t</span>-test); (<b>b</b>) western blot of pAKT and total AKT resulted in bands of 60 kDa.</p>
Full article ">Figure 6
<p>Dexa increases phosphorylation of neural precursor cell expressed, developmentally downregulated 4-like (NEDD4L). (<b>a</b>) Normalized densitometric evaluation of pNEDD4L, NEDD4L and α-tubulin Western blots. Calu-3 cells were treated with 100 nM dexa and mifepristone (10 µM) for 24 h (<span class="html-italic">n</span> = 5; * <span class="html-italic">p</span> &lt; 0.05 by <span class="html-italic">t</span>-test); (<b>b</b>) western blot of pNEDD4L and total NEDD4L resulted in bands of 110 and 135 kDa. Western blot of α-tubulin resulted in bands of 52 kDa; (<b>c</b>) normalized densitometric evaluation of pNEDD4L, NEDD4L and α-tubulin Western blots. Calu-3 cells were treated with 100 nM dexa and Akt1/2 kinase inhibitor (10 µM) or GSK650394 (10 µM) for 24 h (<span class="html-italic">n</span> = 5; * <span class="html-italic">p</span> &lt; 0.05 by <span class="html-italic">t</span>-test); (<b>d</b>) western blot of pNEDD4L and total NEDD4L resulted in bands of 110 and 135 kDa. Western blot of α-tubulin resulted in bands of 52 kDa.</p>
Full article ">Figure 7
<p>Rapid effects of dexa on CFTR activity. Calu-3 cells were treated with 100 nM dexa for 30 min. Data bars represent the mean + SEM. (<b>a</b>) The CFTR<sub>inh</sub>172-sensitive I<sub>SC</sub> was significantly increased by dexa (<span class="html-italic">n</span> = 60, * <span class="html-italic">p</span> &lt; 0.05 by t-test with Welch’s correction); (<b>b</b>) CFTR mRNA expression was not affected by dexa (<span class="html-italic">n</span> = 6); (<b>c</b>) normalized densitometric evaluation of pAKT and AKT Western blots (<span class="html-italic">n</span> = 3; * <span class="html-italic">p</span> &lt; 0.05 by <span class="html-italic">t</span>-test). Western blot of pAKT and total AKT resulted in bands of 60 kDa; (<b>d</b>) normalized densitometric evaluation of pNDRG1 and NDRG1 Western blots (<span class="html-italic">n</span> = 3; * <span class="html-italic">p</span> &lt; 0.05 by <span class="html-italic">t</span>-test). Western blot of pNDRG1 and total NDRG1 resulted in bands of 46 and 48 kDa; (<b>e</b>) normalized densitometric evaluation of pNEDD4L, NEDD4L and α-tubulin Western blots (<span class="html-italic">n</span> = 3; * <span class="html-italic">p</span> &lt; 0.05 by <span class="html-italic">t</span>-test). Western blot of pNEDD4L and total NEDD4L resulted in bands of 110 and 135 kDa. Western blot of α-tubulin resulted in bands of 52 kDa.</p>
Full article ">
2039 KiB  
Article
A Comparison of Lysosomal Enzymes Expression Levels in Peripheral Blood of Mild- and Severe-Alzheimer’s Disease and MCI Patients: Implications for Regenerative Medicine Approaches
by Francesco Morena, Chiara Argentati, Rosa Trotta, Lucia Crispoltoni, Anna Stabile, Alessandra Pistilli, Angela Di Baldassarre, Riccardo Calafiore, Pia Montanucci, Giuseppe Basta, Anna Pedrinolla, Nicola Smania, Massimo Venturelli, Federico Schena, Fabio Naro, Carla Emiliani, Mario Rende and Sabata Martino
Int. J. Mol. Sci. 2017, 18(8), 1806; https://doi.org/10.3390/ijms18081806 - 19 Aug 2017
Cited by 38 | Viewed by 5934
Abstract
The association of lysosomal dysfunction and neurodegeneration has been documented in several neurodegenerative diseases, including Alzheimer’s Disease (AD). Herein, we investigate the association of lysosomal enzymes with AD at different stages of progression of the disease (mild and severe) or with mild cognitive [...] Read more.
The association of lysosomal dysfunction and neurodegeneration has been documented in several neurodegenerative diseases, including Alzheimer’s Disease (AD). Herein, we investigate the association of lysosomal enzymes with AD at different stages of progression of the disease (mild and severe) or with mild cognitive impairment (MCI). We conducted a screening of two classes of lysosomal enzymes: glycohydrolases (β-Hexosaminidase, β-Galctosidase, β-Galactosylcerebrosidase, β-Glucuronidase) and proteases (Cathepsins S, D, B, L) in peripheral blood samples (blood plasma and PBMCs) from mild AD, severe AD, MCI and healthy control subjects. We confirmed the lysosomal dysfunction in severe AD patients and added new findings enhancing the association of abnormal levels of specific lysosomal enzymes with the mild AD or severe AD, and highlighting the difference of AD from MCI. Herein, we showed for the first time the specific alteration of β-Galctosidase (Gal), β-Galactosylcerebrosidase (GALC) in MCI patients. It is notable that in above peripheral biological samples the lysosomes are more sensitive to AD cellular metabolic alteration when compared to levels of Aβ-peptide or Tau proteins, similar in both AD groups analyzed. Collectively, our findings support the role of lysosomal enzymes as potential peripheral molecules that vary with the progression of AD, and make them useful for monitoring regenerative medicine approaches for AD. Full article
(This article belongs to the Special Issue Molecular Research on Neurodegenerative Diseases)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>PBMCs from AD patients have primary hallmark of the disease: (<b>A</b>) Representative Western blotting of β-amyloid and Tau proteins analysis in PBMCs of mild AD, severe AD, MCI, and control subjects; (<b>B</b>,<b>C</b>) Densitometry analyses of both proteins were performed by the Fiji software (see Methods for details) and are reported as ratio toward β-actin protein, selected as reference. Each histogram is the mean ± SEM (standard error of the mean) of all samples analyzed in each group: CTR (<span class="html-italic">n</span> = 13); MCI (<span class="html-italic">n</span> = 10); mild AD (<span class="html-italic">n</span> = 19); and severe AD (<span class="html-italic">n</span> = 17); (<b>D</b>,<b>E</b>) Levels of β-amyloid and Tau proteins were determined in all samples of control group, MCI, mild AD and severe AD patients by using the ELISA assay. Results were expressed as the mean ± SEM of three independent experiments, each in triplicates. *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 2
<p>Lysosomal hydrolases activity (<b>A</b>–<b>E</b>) in PBMCs of mild AD, severe AD, MCI, and control subjects. Levels of hydrolases were measured by using specific fluorogenic substrates (see <a href="#sec4-ijms-18-01806" class="html-sec">Section 4</a> for details). Results were expressed as the mean ± SEM of five independent experiments, each in triplicates. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 3
<p>Lysosomal proteases expression (<b>A</b>–<b>D</b>) in PBMCs of mild AD, severe AD, MCI, and control subjects. Levels of proteases were determined by Western blotting. Shown are the densitometry measurements of all analyses. Results were expressed as the mean ± SEM of five independent experiments, each in triplicates. * <span class="html-italic">p</span> &lt; 0.05.</p>
Full article ">Figure 4
<p>Lysosomal Hydrolases activity (<b>A</b>–<b>E</b>) in plasma of mild AD, severe AD, MCI, and control subjects. Levels of hydrolases were measured by using specific fluorogenic substrates (see <a href="#sec4-ijms-18-01806" class="html-sec">Section 4</a> for details). Results were expressed as the mean ± SEM of five independent experiments, each in triplicates. ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001, **** <span class="html-italic">p</span> &lt; 0.0001.</p>
Full article ">Figure 5
<p>Lysosomal proteases expression (<b>A</b>–<b>D</b>) in plasma of mild AD, severe AD, MCI, and control subjects. Levels of proteases were determined in non-AD control group, mild AD and severe AD patients by using ELISA assay (see the Method section for details). Results were expressed as the mean ± SEM of five independent experiments, each in triplicates. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001.</p>
Full article ">Figure 6
<p>Lysosomal enzymes are able to discriminate mild AD, severe AD, MCI, and control subjects. The Venn diagram illustrated the relationship between mild AD, severe AD, and MCI groups, where lysosomal enzymes showed statistical variation with respect to control group (<b>A</b>–<b>D</b>).</p>
Full article ">
4050 KiB  
Article
Single-Construct Polycistronic Doxycycline-Inducible Vectors Improve Direct Cardiac Reprogramming and Can Be Used to Identify the Critical Timing of Transgene Expression
by Tomohiko C. Umei, Hiroyuki Yamakawa, Naoto Muraoka, Taketaro Sadahiro, Mari Isomi, Sho Haginiwa, Hidenori Kojima, Shota Kurotsu, Fumiya Tamura, Rina Osakabe, Hidenori Tani, Kaori Nara, Hiroyuki Miyoshi, Keiichi Fukuda and Masaki Ieda
Int. J. Mol. Sci. 2017, 18(8), 1805; https://doi.org/10.3390/ijms18081805 - 19 Aug 2017
Cited by 19 | Viewed by 7563
Abstract
Direct reprogramming is a promising approach in regenerative medicine. Overexpression of the cardiac transcription factors Gata4, Mef2c, and Tbx5 (GMT) or GMT plus Hand2 (GHMT) directly reprogram fibroblasts into cardiomyocyte-like cells (iCMs). However, the critical timing of transgene expression and the molecular mechanisms [...] Read more.
Direct reprogramming is a promising approach in regenerative medicine. Overexpression of the cardiac transcription factors Gata4, Mef2c, and Tbx5 (GMT) or GMT plus Hand2 (GHMT) directly reprogram fibroblasts into cardiomyocyte-like cells (iCMs). However, the critical timing of transgene expression and the molecular mechanisms for cardiac reprogramming remain unclear. The conventional doxycycline (Dox)-inducible temporal transgene expression systems require simultaneous transduction of two vectors (pLVX-rtTA/pLVX-cDNA) harboring the reverse tetracycline transactivator (rtTA) and the tetracycline response element (TRE)-controlled transgene, respectively, leading to inefficient cardiac reprogramming. Herein, we developed a single-construct-based polycistronic Dox-inducible vector (pDox-cDNA) expressing both the rtTA and TRE-controlled transgenes. Fluorescence activated cell sorting (FACS) analyses, quantitative RT-PCR, and immunostaining revealed that pDox-GMT increased cardiac reprogramming three-fold compared to the conventional pLVX-rtTA/pLVX-GMT. After four weeks, pDox-GMT-induced iCMs expressed multiple cardiac genes, produced sarcomeric structures, and beat spontaneously. Co-transduction of pDox-Hand2 with retroviral pMX-GMT increased cardiac reprogramming three-fold compared to pMX-GMT alone. Temporal Dox administration revealed that Hand2 transgene expression is critical during the first two weeks of cardiac reprogramming. Microarray analyses demonstrated that Hand2 represses cell cycle-promoting genes and enhances cardiac reprogramming. Thus, we have developed an efficient temporal transgene expression system, which could be invaluable in the study of cardiac reprogramming. Full article
(This article belongs to the Special Issue Stem Cell Research)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Single-construct, polycistronic doxycycline (Dox)-inducible lentiviral vectors promote cardiac reprogramming (<b>A</b>) Conventional two-construct, Dox-inducible lentiviral vectors (left, pLVX-reverse tetracycline transactivator (rtTA) and pLVX-cDNA (green fluorescent protein (GFP), Gata4, Mef2c, Tbx5)), and the new single-construct, polycistronic Dox-inducible lentiviral vectors (right, pDox-cDNA (GFP, Gata4, Mef2c, Tbx5, Hand2)). Horizontal arrows indicate gene expression and diagonal arrows indicate rtTA binding to the tetracycline response element (TRE); (<b>B</b>) Fluorescence activated cell sorting (FACS) analysis of GFP or Humanized Kusabira-Orange fluorescence (hKO) expression one week after pLVX-rtTA/pLVX-GFP or pDox-GFP transduction in mouse embryonic fibroblasts (MEFs).; (<b>C</b>) quantitative data of (<b>B</b>) are shown in (<span class="html-italic">n</span> = 3, independent triplicate experiments); (<b>D</b>) MEFs were infected with pLVX-rtTA/pLVX-GFP or pDox-GFP and were imaged prior to (Dox off), or one week after Dox addition (Dox on), and at the indicated time points after Dox withdrawal (1, 3, 7, and 10 days off). All images were obtained using constant exposure times and identical camera settings; (<b>E</b>) qRT-PCR for Gata4, Mef2c, Tbx5 expression in MEFs, pLVX-rtTA/pLVX-GMT-transduced MEFs, and pDox-GMT-transduced MEFs cultured for one week after Dox addition, as well as in heart tissue (<span class="html-italic">n</span> = 3 independent triplicate experiments). Data were normalized to the values of heart tissue (the dash lines); (<b>F</b>) FACS analyses for cardiac troponin T (cTnT) expression one week after transduction, in the presence of Dox.; (<b>G</b>) quantitative data of (<b>F</b>) (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>H</b>) immunocytochemistry for α-actinin in pDox-GMT-transduced MEFs cultured without or with Dox (i.e., Dox off or Dox on) for four weeks. The high-magnification view in the inset shows the sarcomeric organization; (<b>I</b>) spontaneously beating cardiomyocyte-like cells (iCMs) generated with pDox-GMT transduction, with Dox, after four weeks (arrowheads), corresponding to <a href="#app1-ijms-18-01805" class="html-app">Movie S1</a>. All data are presented as mean ± SD. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 vs. the relevant control. The scale bars represent 100 µm.</p>
Full article ">Figure 2
<p>Cardiac reprogramming is more efficient using pMX-GMT (a Mixture of pMX-Gata4, -Mef2c, and -Tbx5) than that using pDox-GMT (a Mixture of pDox-Gata4, -Mef2c, and -Tbx5). (<b>A</b>) qRT-PCR for Gata4, Mef2c, and Tbx5 expression in mouse embryonic fibroblasts (MEFs), pDox-GMT-transduced MEFs, pMX-GMT-transduced MEFs, and heart tissue (<span class="html-italic">n</span> = 3, independent triplicate experiments). Data were normalized to the values of heart tissue (the dash lines); (<b>B</b>) qRT-PCR for TnnT2, Myh6, Nppa, and Ryr2 mRNA expression in mouse embryonic fibroblasts (MEFs), pDox-GMT-transduced MEFs and pMX-GMT-transduced MEFs after one week (<span class="html-italic">n</span> = 3 independent triplicate experiments). Data were normalized to the values of pDox-GMT-transduced MEFs (the dash lines); (<b>C</b>) FACS analyses of cardiac troponin T (cTnT) expression induced by pDox-GMT in the presence of Dox or pMX-GMT after one week; (<b>D</b>) quantitative data of (<b>C</b>) (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>E</b>) immunocytochemistry for α-actinin in pDox-GMT-transduced MEFs in the presence of Dox, and pMX-GMT-transduced MEFs, after four weeks. The high-magnification views in the insets show the sarcomeric organization; (<b>F</b>) quantitation of α-actinin-positive cells (<span class="html-italic">n</span> = 3 independent triplicate experiments). All data are presented as mean ± SD. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 vs. the relevant control. The scale bars represent 100 µm.</p>
Full article ">Figure 2 Cont.
<p>Cardiac reprogramming is more efficient using pMX-GMT (a Mixture of pMX-Gata4, -Mef2c, and -Tbx5) than that using pDox-GMT (a Mixture of pDox-Gata4, -Mef2c, and -Tbx5). (<b>A</b>) qRT-PCR for Gata4, Mef2c, and Tbx5 expression in mouse embryonic fibroblasts (MEFs), pDox-GMT-transduced MEFs, pMX-GMT-transduced MEFs, and heart tissue (<span class="html-italic">n</span> = 3, independent triplicate experiments). Data were normalized to the values of heart tissue (the dash lines); (<b>B</b>) qRT-PCR for TnnT2, Myh6, Nppa, and Ryr2 mRNA expression in mouse embryonic fibroblasts (MEFs), pDox-GMT-transduced MEFs and pMX-GMT-transduced MEFs after one week (<span class="html-italic">n</span> = 3 independent triplicate experiments). Data were normalized to the values of pDox-GMT-transduced MEFs (the dash lines); (<b>C</b>) FACS analyses of cardiac troponin T (cTnT) expression induced by pDox-GMT in the presence of Dox or pMX-GMT after one week; (<b>D</b>) quantitative data of (<b>C</b>) (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>E</b>) immunocytochemistry for α-actinin in pDox-GMT-transduced MEFs in the presence of Dox, and pMX-GMT-transduced MEFs, after four weeks. The high-magnification views in the insets show the sarcomeric organization; (<b>F</b>) quantitation of α-actinin-positive cells (<span class="html-italic">n</span> = 3 independent triplicate experiments). All data are presented as mean ± SD. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 vs. the relevant control. The scale bars represent 100 µm.</p>
Full article ">Figure 3
<p>Initiating expression of Hand2 transgene one day after transduction promotes cardiac reprogramming. (<b>A</b>) Schematic representation of Hand2 transgene expression with temporal Dox addition. Mouse embryonic fibroblasts (MEFs) were infected with a mixture of pDox-Hand2 and pMX-GMT, and then Dox was added at day 1 (D1 on), day 3 (D3 on), and day 7 (D7 on) following transduction. Dox off indicates without Dox and pMX-GHMT (GMT plus Hand2) is the positive control; (<b>B</b>) qRT-PCR for Hand2 expression in the indicated samples after two weeks (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>C</b>) FACS analyses of cardiac troponin T (cTnT) expression in the indicated samples after two weeks; (<b>D</b>) quantitative data of (<b>C</b>) (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>E</b>) immunocytochemistry for α-actinin and cTnT after four weeks. The high-magnification views in the insets show the sarcomeric organization in cardiomyocyte-like cells (iCMs); (<b>F</b>) quantitation of the immunopositive (α-actinin<sup>+</sup> and cTnT<sup>+</sup>) cells (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>G</b>) total number of Ca<sup>2+</sup> oscillation<sup>+</sup> cells in ten randomly selected fields per well after four weeks (<span class="html-italic">n</span> = 3 independent triplicate experiments). <a href="#app1-ijms-18-01805" class="html-app">Movie S2</a> shows Ca<sup>2+</sup> imaging; (<b>H</b>) spontaneously beating iCMs in the pDox-Hand2/pMX-GMT-transduced MEFs after four weeks (D1 on, arrowheads), corresponding to <a href="#app1-ijms-18-01805" class="html-app">Movie S3</a>; (<b>I</b>) total number of beating cells in ten randomly selected fields per well (<span class="html-italic">n</span> = 3 independent triplicate experiments). All data are presented as mean ± SD. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 vs. the relevant control; NS = not significant. The scale bars represent 100 µm.</p>
Full article ">Figure 4
<p><span class="html-italic">Hand2</span> transgene expression for the first two weeks is sufficient to promote cardiac reprogramming. (<b>A</b>) Time course of the total number of beating cardiomyocyte-like cells (iCMs) in mouse embryonic fibroblasts (MEFs) induced with pDox-Hand2/pMX-GMT or pMX-GMT after two and four weeks (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>B</b>) schematic representation of the strategy to determine the optimal timing of Hand2 expression for cardiac reprogramming. Doxycycline (Dox) was administered for different intervals, four weeks (D1 on), seven days (D7 off), and fourteen days (D14 off), after transduction of cells with pDox-Hand2/pMX-GMT; (<b>C</b>) qRT-PCR for Hand2 expression in the indicated samples after four weeks (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>D</b>) FACS analyses for cardiac troponin T (cTnT) expression in the indicated samples after four weeks. Quantitative data are shown (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>E</b>) immunocytochemistry for α-actinin and cTnT after four weeks. The high-magnification views in the insets show the sarcomeric organization; (<b>F</b>) quantitation of immunopositive (α-actinin<sup>+</sup> and cTnT<sup>+</sup>) cells (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>G</b>) total number of Ca<sup>2+</sup> oscillation<sup>+</sup> cells in ten randomly selected fields per well after four weeks (<span class="html-italic">n</span> = 3 independent triplicate experiments); (<b>H</b>) total number of spontaneously beating cells ten randomly selected fields per well after four weeks (<span class="html-italic">n</span> = 3 independent triplicate experiments). All data are presented as mean ± SD. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 vs. the relevant control; NS = not significant. The scale bars represent 100 µm.</p>
Full article ">Figure 5
<p>Hand2 represses cell cycle-promoting genes during cardiac reprogramming. (<b>A</b>) Microarray analyses of FACS-sorted α myosin heavy chain (αMHC)-GFP<sup>+</sup> cells induced with pMX-GMT or pMX-GHMT after two (2W) and four weeks (4W). Red indicates increased gene expression, whereas green indicates decreased gene expression; (<b>B</b>) gene ontology (GO) term analyses for the upregulated genes in GHMT–iCMs (cardiomyocyte-like cells) compared to expression in GMT-iCMs after four weeks. Cardiac-related GO categories are shown; (<b>C</b>) GO term analyses for the downregulated genes in GHMT-iCMs compared to expression in GMT-iCMs after four weeks. Cell cycle-related GO categories are shown; (<b>D</b>) heatmap images of the gene expression patterns of cardiac- and cell cycle-related genes; (<b>E</b>) the relative mRNA expression of the indicated genes was determined by qRT-PCR (<span class="html-italic">n</span> = 3 independent triplicate experiments). All data are presented as mean ± SD. * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01 vs. the relevant control. The scales are −1 to 1 in log2.</p>
Full article ">
615 KiB  
Review
FANCD2 and DNA Damage
by Manoj Nepal, Raymond Che, Chi Ma, Jun Zhang and Peiwen Fei
Int. J. Mol. Sci. 2017, 18(8), 1804; https://doi.org/10.3390/ijms18081804 - 19 Aug 2017
Cited by 46 | Viewed by 9597
Abstract
Investigators have dedicated considerable effort to understanding the molecular basis underlying Fanconi Anemia (FA), a rare human genetic disease featuring an extremely high incidence of cancer and many congenital defects. Among those studies, FA group D2 protein (FANCD2) has emerged as the focal [...] Read more.
Investigators have dedicated considerable effort to understanding the molecular basis underlying Fanconi Anemia (FA), a rare human genetic disease featuring an extremely high incidence of cancer and many congenital defects. Among those studies, FA group D2 protein (FANCD2) has emerged as the focal point of FA signaling and plays crucial roles in multiple aspects of cellular life, especially in the cellular responses to DNA damage. Here, we discuss the recent and relevant studies to provide an updated review on the roles of FANCD2 in the DNA damage response. Full article
(This article belongs to the Special Issue DNA Injury and Repair Systems)
Show Figures

Figure 1

Figure 1
<p>Outline of FA group D2 protein (FANCD2) functions under stressed conditions. In stressed cells, ataxia telangiectasia and Rad3-related protein (ATR) or ataxia telangiectasia mutated (ATM) is activated upon the generation of DNA single or double strand breaks (SSB or DSB), respectively. FANCD2 activation/monoubiquitination issued from the Fanconi anemia (FA) core complex E3 and an E2 (FANCT) can be promoted by the phosphorylation of FANCI triggered by activated ATR, thus conducting important roles that have originated from the activation of ATR. FANCD2 can also play roles not only in aiding ATM signaling for S phase arrest through ATM-dependent phosphorylation at S222 but also possibly in facilitating the initiation of ATM signaling far more upstream via its involvement in the phosphorylation of H2AX. Furthermore, human homologs of yeast Rad6 (HHR6) &amp; hRad18 are also capable of regulating the functions of FANCD2, together influencing the functions of the downstream partners of FANCD2, including Fanconi-associated nuclease 1 (FAN1), DNA polymerase eta (Pol eta), and many others known or yet to be identified.</p>
Full article ">
305 KiB  
Review
Platelet Aggregometry Testing: Molecular Mechanisms, Techniques and Clinical Implications
by Katalin Koltai, Gabor Kesmarky, Gergely Feher, Antal Tibold and Kalman Toth
Int. J. Mol. Sci. 2017, 18(8), 1803; https://doi.org/10.3390/ijms18081803 - 18 Aug 2017
Cited by 91 | Viewed by 11813
Abstract
Platelets play a fundamental role in normal hemostasis, while their inherited or acquired dysfunctions are involved in a variety of bleeding disorders or thrombotic events. Several laboratory methodologies or point-of-care testing methods are currently available for clinical and experimental settings. These methods describe [...] Read more.
Platelets play a fundamental role in normal hemostasis, while their inherited or acquired dysfunctions are involved in a variety of bleeding disorders or thrombotic events. Several laboratory methodologies or point-of-care testing methods are currently available for clinical and experimental settings. These methods describe different aspects of platelet function based on platelet aggregation, platelet adhesion, the viscoelastic properties during clot formation, the evaluation of thromboxane metabolism or certain flow cytometry techniques. Platelet aggregometry is applied in different clinical settings as monitoring response to antiplatelet therapies, the assessment of perioperative bleeding risk, the diagnosis of inherited bleeding disorders or in transfusion medicine. The rationale for platelet function-driven antiplatelet therapy was based on the result of several studies on patients undergoing percutaneous coronary intervention (PCI), where an association between high platelet reactivity despite P2Y12 inhibition and ischemic events as stent thrombosis or cardiovascular death was found. However, recent large scale randomized, controlled trials have consistently failed to demonstrate a benefit of personalised antiplatelet therapy based on platelet function testing. Full article
(This article belongs to the Special Issue Mechanisms of Platelet Thrombus Formation)
2284 KiB  
Article
EpCAM Expression in Lymph Node Metastases of Urothelial Cell Carcinoma of the Bladder: A Pilot Study
by Christa A. M. Van der Fels, Stefano Rosati and Igle J. De Jong
Int. J. Mol. Sci. 2017, 18(8), 1802; https://doi.org/10.3390/ijms18081802 - 18 Aug 2017
Cited by 11 | Viewed by 5282
Abstract
In this retrospective pilot study, the feasibility of the epithelial cell adhesion molecule (EpCAM) as an imaging target for lymph node (LN) metastatic disease of urothelial cell carcinoma (UCC) of the bladder was investigated. LN metastases and LNs without metastases of patients who [...] Read more.
In this retrospective pilot study, the feasibility of the epithelial cell adhesion molecule (EpCAM) as an imaging target for lymph node (LN) metastatic disease of urothelial cell carcinoma (UCC) of the bladder was investigated. LN metastases and LNs without metastases of patients who underwent pelvic lymph node dissection because of muscle invasive bladder cancer (MIBC) were used. Primary tumors of the same patients were used from cystectomy specimen, transurethral resections, and biopsies. A pathologist, blinded to clinical data, scored EpCAM immunoreactivity. This method determines a total immunostaining score, which is the product of a proportion score and an intensity score. EpCAM expression was observed in 19/20 (95%) LNs with UCC metastases and in 11/12 (92%) of the primary tumors. EpCAM expression was absent in 14/14 (100%) LNs without metastases. Median EpCAM expression (TIS) in LN metastases was 5 (IQR 2.0–8.0) and in the primary tumors 6 (IQR 2.3–11.0). Based on the absence of staining in LNs without metastases, EpCAM show high tumor distinctiveness. EpCAM seems to be a feasible imaging target in LN metastases of UCC of the bladder. Pre- and perioperative visualization of these metastases will improve disease staging and improve the complete resection of LN metastases in MIBC. Full article
(This article belongs to the Special Issue Molecular Research on Urology)
Show Figures

Figure 1

Figure 1
<p>Normal lymph node without EpCAM expression and lymph node metastases with EpCAM expression with intensity score <b>1</b>: weak; <b>2</b>: moderate; and <b>3</b>: strong. Original magnification: 200×.</p>
Full article ">Figure 2
<p>Lymph node metastasis without EpCAM expression. Lymph node metastases with EpCAM expression with proportion score <b>2</b>: 10–50%; <b>3</b>: 51–80%; and <b>4</b>: &gt;80%. Original magnification: 200×.</p>
Full article ">Figure 3
<p>Primary tumor in urinary bladder without EpCAM expression and with EpCAM expression with intensity score <b>1</b>: weak; <b>2</b>: moderate; and <b>3</b>: strong. Original magnification: 200×.</p>
Full article ">
2620 KiB  
Article
Enhanced Susceptibility of Ogg1 Mutant Mice to Multiorgan Carcinogenesis
by Anna Kakehashi, Naomi Ishii, Takahiro Okuno, Masaki Fujioka, Min Gi and Hideki Wanibuchi
Int. J. Mol. Sci. 2017, 18(8), 1801; https://doi.org/10.3390/ijms18081801 - 18 Aug 2017
Cited by 15 | Viewed by 4682
Abstract
The role of deficiency of oxoguanine glycosylase 1 (Ogg1) Mmh homolog, a repair enzyme of the 8-hydroxy-2’-deoxyguanosine (8-OHdG) residue in DNA, was investigated using the multiorgan carcinogenesis bioassay in mice. A total of 80 male and female six-week-old mice of C57BL/6J [...] Read more.
The role of deficiency of oxoguanine glycosylase 1 (Ogg1) Mmh homolog, a repair enzyme of the 8-hydroxy-2’-deoxyguanosine (8-OHdG) residue in DNA, was investigated using the multiorgan carcinogenesis bioassay in mice. A total of 80 male and female six-week-old mice of C57BL/6J background carrying a mutant Mmh allele of the Mmh/Ogg1 gene (Ogg1/) and wild type (Ogg1+/+) mice were administered N-diethylnitrosamine (DEN), N-methyl-N-nitrosourea (MNU), N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN), N-bis (2-hydroxypropyl) nitrosamine (DHPN) and 1,2-dimethylhydrazine dihydrochloride (DMH) (DMBDD) to induce carcinogenesis in multiple organs, and observed up to 34 weeks. Significant increase of lung adenocarcinomas incidence was observed in DMBDD-treated Ogg1/ male mice, but not in DMBDD-administered Ogg1+/+ animals. Furthermore, incidences of lung adenomas were significantly elevated in both Ogg1/ males and females as compared with respective Ogg1/ control and DMBDD-treated Ogg1+/+ groups. Incidence of total liver tumors (hepatocellular adenomas, hemangiomas and hemangiosarcomas) was significantly higher in the DMBDD-administered Ogg1/ males and females. In addition, in DMBDD-treated male Ogg1/ mice, incidences of colon adenomas and total colon tumors showed a trend and a significant increase, respectively, along with significant rise in incidence of simple hyperplasia of the urinary bladder, and a trend to increase for renal tubules hyperplasia in the kidney. Furthermore, incidence of squamous cell hyperplasia in the forestomach of DMBDD-treated Ogg1/ male mice was significantly higher than that of Ogg1+/+ males. Incidence of small intestine adenomas in DMBDD Ogg1/ groups showed a trend for increase, as compared to the wild type mice. The current results demonstrated increased susceptibility of Ogg1 mutant mice to the multiorgan carcinogenesis induced by DMBDD. The present bioassay could become a useful tool to examine the influence of various targets on mouse carcinogenesis. Full article
(This article belongs to the Special Issue Chemically-Induced DNA Damage, Mutagenesis, and Cancer)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Body weight (<b>A</b>); and survival (<b>B</b>) curves for DMBDD-treated and control <span class="html-italic">Ogg1</span><sup>−/−</sup> and <span class="html-italic">Ogg1</span><sup>+/+</sup> male and female mice. *** <span class="html-italic">p</span> &lt; 0.001 significantly different vs. respective control group of the same genotype; <sup>a</sup> <span class="html-italic">p</span> &lt; 0.05 and <sup>c</sup> <span class="html-italic">p</span> &lt; 0.001 significantly different vs. the respective <span class="html-italic">Ogg1</span><sup>+/+</sup> control groups.</p>
Full article ">Figure 2
<p>Representative histopathological pictures (H&amp;E staining) of: lung hyperplasia (<b>a</b>); adenoma (<b>b</b>); adenocarcinoma (<b>c</b>); liver PPF (basophilic foci) (<b>d</b>); HCA (<b>e</b>); hemangioma (<b>f</b>); hemangiosarcoma (<b>g</b>); colon adenoma (<b>h</b>); and adenocarcinoma (<b>i</b>) developed in DMBDD-treated <span class="html-italic">Ogg1</span><sup>−/−</sup> mice. HPL, hyperplasia; HCA, hepatocellular adenoma; AdCa, adenocarcinoma; PPFs, putative preneoplastic foci.</p>
Full article ">Figure 3
<p>Experimental protocol of medium-term multiorgan carcinogenesis bioassay applied in <span class="html-italic">Ogg1</span><sup>−/−</sup> and <span class="html-italic">Ogg1</span><sup>+/+</sup> mice. wks: weeks.</p>
Full article ">
1705 KiB  
Article
Determination of Sphingosine-1-Phosphate in Human Plasma Using Liquid Chromatography Coupled with Q-Tof Mass Spectrometry
by Emmanuel E. Egom, Ross Fitzgerald, Rebecca Canning, Rebabonye B. Pharithi, Colin Murphy and Vincent Maher
Int. J. Mol. Sci. 2017, 18(8), 1800; https://doi.org/10.3390/ijms18081800 - 18 Aug 2017
Cited by 10 | Viewed by 6139
Abstract
Evidence suggests that high-density lipoprotein (HDL) components distinct from cholesterol, such as sphingosine-1-phosphate (S1P), may account for the anti-atherothrombotic effects attributed to this lipoprotein. The current method for the determination of plasma levels of S1P as well as levels associated with HDL particles [...] Read more.
Evidence suggests that high-density lipoprotein (HDL) components distinct from cholesterol, such as sphingosine-1-phosphate (S1P), may account for the anti-atherothrombotic effects attributed to this lipoprotein. The current method for the determination of plasma levels of S1P as well as levels associated with HDL particles is still cumbersome an assay method to be worldwide practical. Recently, a simplified protocol based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for the sensitive and specific quantification of plasma levels of S1P with good accuracy has been reported. This work utilized a triple quadrupole (QqQ)-based LC-MS/MS system. Here we adapt that method for the determination of plasma levels of S1P using a quadrupole time of flight (Q-Tof) based LC-MS system. Calibration curves were linear in the range of 0.05 to 2 µM. The lower limit of quantification (LOQ) was 0.05 µM. The concentration of S1P in human plasma was determined to be 1 ± 0.09 µM (n = 6). The average accuracy over the stated range of the method was found to be 100 ± 5.9% with precision at the LOQ better than 10% when predicting the calibration standards. The concentration of plasma S1P in the prepared samples was stable for 24 h at room temperature. We have demonstrated the quantification of plasma S1P using Q-Tof based LC-MS with very good sensitivity, accuracy, and precision that can used for future studies in this field. Full article
(This article belongs to the Section Biochemistry)
Show Figures

Figure 1

Figure 1
<p>Representative extracted ion chromatogram (EIC) at <span class="html-italic">m</span>/<span class="html-italic">z</span> 380.2560 corresponding to the [M + H]<sup>+</sup> ion of sphingosine-1-phosphate (S1P). S1P elution time and peak shape are illustrated. The retention time corresponds to that determined for the standards.</p>
Full article ">Figure 2
<p>Comparison between the Waters X-Select CSH column, as used previously [<a href="#B32-ijms-18-01800" class="html-bibr">32</a>] (Red), and a Phenomenex Kinetex EVO C18 used here (Green).</p>
Full article ">Figure 3
<p>(<b>A</b>) When only the ions of interest are extracted [M+H]<sup>+</sup>, both mass accuracy and isotope pattern are consistent with the presence of S1P. The black lines are the spectrum overlaid with predicted isotope pattern; (<b>B</b>) Representative raw spectrum extracted under the S1P peak with background subtracted. The evidence of blood proteins (probably serum albumin) co-eluting is shown by the peaks in the charge envelope between ~700 and 1500 <span class="html-italic">m</span>/<span class="html-italic">z</span>.</p>
Full article ">Figure 4
<p>1/<span class="html-italic">x</span> weighted calibration curve recommended to be used. Black dots: calibration standards; blue triangles: QC samples; pink arrow: denotes human plasma. Black dots represent calibration standards; blue triangles are QC samples and pink arrow is a human plasma sample.</p>
Full article ">Figure 5
<p>Non-weighted linear regression calibration curve of three injection replicates at seven calibration levels (4 to 10) (0.05 to 4.5 µM) with very good correlation and linearity over the entire range. The heteroscedasticity of the data is clear with absolute variance increasing with concentration. Black dots represent calibration standards; blue triangles are QC samples.</p>
Full article ">Figure 6
<p>The data is heteroscedastic and would be better modelled using a weighted linear regression. Plot of the positive and negative standard deviation against calibration levels show increased absolute variation with increasing concentration.</p>
Full article ">Figure 7
<p>Response/concentration ratio is constant from 1.5 to 4.5 µM with a decline noticeable at 0.05 µM.</p>
Full article ">Figure 8
<p>The consistency of the signal over greater than 12 h and 50 injections demonstrates the stability of the instrument and the samples. (Quality control and calibration injections were performed between the above replicates).</p>
Full article ">
3575 KiB  
Review
Aquaporin-4 Functionality and Virchow-Robin Space Water Dynamics: Physiological Model for Neurovascular Coupling and Glymphatic Flow
by Tsutomu Nakada, Ingrid L. Kwee, Hironaka Igarashi and Yuji Suzuki
Int. J. Mol. Sci. 2017, 18(8), 1798; https://doi.org/10.3390/ijms18081798 - 18 Aug 2017
Cited by 61 | Viewed by 13731
Abstract
The unique properties of brain capillary endothelium, critical in maintaining the blood-brain barrier (BBB) and restricting water permeability across the BBB, have important consequences on fluid hydrodynamics inside the BBB hereto inadequately recognized. Recent studies indicate that the mechanisms underlying brain water dynamics [...] Read more.
The unique properties of brain capillary endothelium, critical in maintaining the blood-brain barrier (BBB) and restricting water permeability across the BBB, have important consequences on fluid hydrodynamics inside the BBB hereto inadequately recognized. Recent studies indicate that the mechanisms underlying brain water dynamics are distinct from systemic tissue water dynamics. Hydrostatic pressure created by the systolic force of the heart, essential for interstitial circulation and lymphatic flow in systemic circulation, is effectively impeded from propagating into the interstitial fluid inside the BBB by the tightly sealed endothelium of brain capillaries. Instead, fluid dynamics inside the BBB is realized by aquaporin-4 (AQP-4), the water channel that connects astrocyte cytoplasm and extracellular (interstitial) fluid. Brain interstitial fluid dynamics, and therefore AQP-4, are now recognized as essential for two unique functions, namely, neurovascular coupling and glymphatic flow, the brain equivalent of systemic lymphatics. Full article
(This article belongs to the Special Issue Cerebral Blood Flow and Metabolism)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Capillaries. Common capillaries have a leaky endothelium due to the presence of fenestrations. The water channel aquaporin-1 (AQP-1) is also abundantly expressed. Accordingly, water dynamics between intracapillary and interstitial fluid space is directly connected (right). In contrast, brain capillaries lack fenestrations and have tight junctions. Expression of AQP-1 is actively suppressed. As a result, water dynamics in the intracapillary space and interstitial fluid space are effectively isolated from each other and must be analyzed independently. Modified from Reference [<a href="#B9-ijms-18-01798" class="html-bibr">9</a>].</p>
Full article ">Figure 2
<p>The experimental set-up known as a Starling resistor. An elastic tube clamped between rigid tubes is surrounded by an outer pressure chamber. Flow is driven through the tube from left to right by an applied pressure differences, <span class="html-italic">P<sub>up</sub></span>-<span class="html-italic">P<sub>dn</sub></span>. The pressure of the chamber, <span class="html-italic">P<sub>ext</sub></span>, can be adjusted to control the average diameter of the elastic tube. <span class="html-italic">P<sub>up</sub></span>: upstream pressure; <span class="html-italic">P<sub>dn</sub></span>: downstream pressure; <span class="html-italic">P<sub>ext</sub></span>: external chamber pressure.</p>
Full article ">Figure 3
<p>Peri-capillary VRS water dynamics. Brain capillary endothelial tight junctions and active suppression of AQP-1 expression highly restricts water movement across the BBB. By contrast, significant water flow (blue arrow) is present inside the BBB within VRS (interstitial flow), mediated by active water inflow through AQP-4. Modified from Reference [<a href="#B9-ijms-18-01798" class="html-bibr">9</a>].</p>
Full article ">Figure 4
<p>Molecular processes within the Virchow–Robin space associated with neural activation. Neural activation induces potassium efflux into the interstitial space which is quickly scavenged by inwardly rectifying potassium channel (Kir). This potassium spatial buffering promotes release of a counterpart cation, H<sup>+</sup>, by vacuolar ATPase, resulting in proton excess in the interstitial fluid (extracellular acidosis). AQP-4 is inhibited by higher proton density (red arrow). Excess protons move into the intracapillary space without significant resistance at the tight junctions because of the Grotthuss proton tunneling mechanism. Carbonic anhydrase type IV (CA-IV) anchored to the luminal surface of capillaries and NBC1 sodium bicarbonate co-transporter that interacts directly with CA-IV effectively scavenge these excess protons. Modified from Reference [<a href="#B9-ijms-18-01798" class="html-bibr">9</a>].</p>
Full article ">Figure 5
<p>At the VRS, neural activation produces extracellular acidification accompanied by increase in rCBF and astrocyte swelling. Proton inhibition of AQP-4 results in a reduction of water flow from astrocytes into the peri-capillary Virchow-Robin space, reduction of peri-capillary fluid pressure, capillary lumen expansion, increase rCBF and astrocyte swelling. Modified from Reference [<a href="#B9-ijms-18-01798" class="html-bibr">9</a>].</p>
Full article ">Figure 6
<p>Schematic presentation of wave propagation simulation for conceptualizing water dynamics inside the BBB. From a hydrodynamic standpoint, the tight endothelium of brain capillaries forming the BBB is seriously flawed. While hydrostatic pressure generated by the systolic force of the heart (blue arrow) provides the necessary kinetics in the case of fenestrated capillaries (<b>left</b>), sealed capillaries impede propagation of such a force (<b>middle</b>). The addition of AQP-4 driven water flow reconstitutes the necessary environment (<b>right</b>). Diagrams are created using wave propagation/interference simulation for two windows.</p>
Full article ">Figure 7
<p>Astrocyte and polarized localization of AQP-4. (<b>A</b>): Expression of AQP-4 in the brain is highly polarized to endfeet of astrocytes at two specific locations, the glia limitans externa (GLE) at the cortical surface and peri-capillary Virchow-Robin space (VRS). VRS constitutes fluid-filled canals surrounding perforating arteries, capillaries, and veins in brain parenchyma. While pia mater ends near the brain surface, VRS continues into the brain parenchyma accompanying a perforating artery; (<b>B</b>): Astrocyte endfeet attach to many structures. However, AQP-4 is found only at the GLE and VRS.</p>
Full article ">Figure 8
<p>AQP-4 circulator model. The AQP-4 system provides additional water flow into peri-capillary VRS (thick blue arrow). Water enters astrocytes through AQP-4 at the GLE. This internal circulation further promotes appropriate interstitial fluid dynamics including flow through VRS (interstitial flow), otherwise known as glymphatic flow.</p>
Full article ">
3786 KiB  
Article
Immune-Response Patterns and Next Generation Sequencing Diagnostics for the Detection of Mycoses in Patients with Septic Shock—Results of a Combined Clinical and Experimental Investigation
by Sebastian O. Decker, Annette Sigl, Christian Grumaz, Philip Stevens, Yevhen Vainshtein, Stefan Zimmermann, Markus A. Weigand, Stefan Hofer, Kai Sohn and Thorsten Brenner
Int. J. Mol. Sci. 2017, 18(8), 1796; https://doi.org/10.3390/ijms18081796 - 18 Aug 2017
Cited by 47 | Viewed by 13033
Abstract
Fungi are of increasing importance in sepsis. However, culture-based diagnostic procedures are associated with relevant weaknesses. Therefore, culture- and next-generation sequencing (NGS)-based fungal findings as well as corresponding plasma levels of β-d-glucan, interferon gamma (INF-γ), tumor necrosis factor alpha (TNF-α), interleukin [...] Read more.
Fungi are of increasing importance in sepsis. However, culture-based diagnostic procedures are associated with relevant weaknesses. Therefore, culture- and next-generation sequencing (NGS)-based fungal findings as well as corresponding plasma levels of β-d-glucan, interferon gamma (INF-γ), tumor necrosis factor alpha (TNF-α), interleukin (IL)-2, -4, -6, -10, -17A, and mid-regional proadrenomedullin (MR-proADM) were evaluated in 50 septic patients at six consecutive time points within 28 days after sepsis onset. Furthermore, immune-response patterns during infections with Candida spp. were studied in a reconstituted human epithelium model. In total, 22% (n = 11) of patients suffered from a fungal infection. An NGS-based diagnostic approach appeared to be suitable for the identification of fungal pathogens in patients suffering from fungemia as well as in patients with negative blood cultures. Moreover, MR-proADM and IL-17A in plasma proved suitable for the identification of patients with a fungal infection. Using RNA-seq., adrenomedullin (ADM) was shown to be a target gene which is upregulated early after an epithelial infection with Candida spp. In summary, an NGS-based diagnostic approach was able to close the diagnostic gap of routinely used culture-based diagnostic procedures, which can be further facilitated by plasmatic measurements of MR-proADM and IL-17A. In addition, ADM was identified as an early target gene in response to epithelial infections with Candida spp. Full article
(This article belongs to the Special Issue Sepsis)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Identification of fungal pathogens in patients with septic shock (<span class="html-italic">n</span> = 50).</p>
Full article ">Figure 2
<p>Time course (fungal) SIQ analyses compared with conventional clinical microbiology data of septic patients. The anti-infective treatment regime and (fungal) SIQ scores for species identified via NGS of the respective plasma samples are reported for a time course of 28 days (indicated by the <span class="html-italic">x</span>-axis) for patients S16 (<b>A</b>), S25 (<b>B</b>), and S35 (<b>C</b>). Only species identified by SIQ-score analyses are indicated at the left side. Red colored boxes reveal ranking of highest SIQ scores for the respective species in every patient. Pertinent (clinical microbiology) laboratory results are marked using arrows to indicate the day the clinical specimen was obtained. (<b>A</b>) A 73-year old male patient presented with a tumor of his bile duct with the need for a palliative resection. The surgical procedure included resections of the bile duct as well as the gallbladder and was followed by a double bypass procedure (biliodigestive anastomosis and gastrojejunal anastomosis). Four days after the initial operation the patient suffered from septic shock due to a duodenal ulcer perforation with the need for a total pancreatectomy. Shortly after, the patient suffered from another small bowel leakage, so that an additional small bowel resection had to be performed. Blood cultures at sepsis onset were shown to be negative, and meropenem (MEM) was administered in terms of an empiric antibiotic therapy. However, the patient suffered from a therapy-refractory course of the disease and <span class="html-italic">C. albicans</span> could be isolated from abdominal drainage fluids 6 days after sepsis onset. Accordingly, an additional antifungal treatment with fluconazole (FLC) was initiated. Due to the development of candidemia at 14 days after sepsis onset, this antifungal treatment regime was secondarily escalated towards caspofungin (CFG). These findings were in good agreement with next generation sequencing (NGS) diagnostics in plasma, since the SIQ-score was positive for <span class="html-italic">C. albicans</span> at the same timepoint. Abbreviations: NGS, next generation sequencing; SIQ, sepsis indicating quantifier; MEM, meropenem; IPM:CIL, imipenem/cilastatin; FLC, fluconazole; DOR, doripenem; CFG, caspofungin; BC, blood culture; CVC, central venous catheter; TS, tracheal secretion; (<b>B</b>) A 65-year old male patient suffered from a Klatskin tumor with the need for a right-sided hemihepatectomy. Due to an abscess at the resection site, the patient suffered from septic shock with the need for an interventional drainage 22 days after the initial operation. The further course was complicated by the development of a right-sided pleural empyema as well as recurrent intra-abdominal abscesses, which were both treated with repeated placements of interventional drainages. Empiric antibiotic therapy at sepsis onset included imipenem/cilastatin (IMP:CIL) in terms of a monotherapy. Culture-based microbiological diagnostics revealed no bacterial growth, whereas <span class="html-italic">C. glabrata</span> could be detected in both fluids of already positioned drainages as well as fresh puncture materials respectively. Based on these microbiological findings, the patient was classified as infected, so that an administration of caspofungin was started at 14 days after sepsis onset. Blood cultures remained negative for fungi at all time points. Contrariwise, a next generation sequencing (NGS)-based diagnostic approach in plasma samples of septic patients was able to support the presence of an invasive fungal infection already at 7 days after sepsis onset, since the SIQ-score was shown to be positive for <span class="html-italic">C. glabrata</span> at this time point. Unfortunately, a further evaluation of the patient’s course of the disease beyond 14 days after sepsis onset was not possible, since the patient denied further participation in the study. Abbreviations: CFG, caspofungin; IMP:CIL, imipenem/cilastatin; na, not available; nd, not detectable; NGS, next generation sequencing; SIQ, sepsis indicating; (<b>C</b>) A 71-year-old female patient presented with a right pleural empyema caused by a liver abscess with the need for a video-assisted thoracoscopy (VATS). One day after VATS, the patient suffered from an acute abdomen with septic shock due to a perforation of the sigmoid colon, so that a removal of the sigmoid colon had to be performed. A second explorative laparotomy was necessary at 10 days after sepsis onset, due to a messy drainage fluid with a suspicion of another bowel leakage. However, during the revision surgery no clear focus could be found. Empiric anti-infective treatment consisted of imipenem/cilastatin (IMP:CIL) in combination with fluconazole (FLC), which was further supplemented by vancomycin (VAC) for 2 days in the early phase after sepsis onset. Anti-infective treatment was stepwise deescalated, so that the patient was free of any antibiotics or antimycotics at 12 days after sepsis onset. In the further course of the disease, the administration of caspofungin (CFG) was started at 20 days after sepsis onset, since the patient did not recover well and drainage fluids were shown to be positive for <span class="html-italic">Candida</span> spp. repeatedly starting from 3 days after sepsis onset. In parallel, next generation sequencing (NGS)-based diagnostics revealed a positive SIQ-score for <span class="html-italic">C. glabrata</span> also at 3 days after sepsis onset, whereas blood cultures were found to be negative for fungi throughout the whole observation period. The end of the 28 day-observation period was further characterized by an insufficiency of the stump by Hartmann as well as the development of severe pneumonia with the key bacteria Pseudomonas aeruginosa and Enterococcus faecalis, so that another antibiotic treatment phase with piperacillin/tazobactam as well as inhaled tobramycin was initiated. Abbreviations: BC, blood culture; BL, bronchoalveolar lavage; CFG, caspofungin; FLC, fluconazole; IMP:CIL, imipenem/cilastatin; n.a, not available; NGS, next generation sequencing; SIQ, sepsis indicating quantifier; TBC, inhaled tobramycine, TS, tracheal secretion; TZP, piperacilline/tazobactam; VAC, vancomycin.</p>
Full article ">Figure 2 Cont.
<p>Time course (fungal) SIQ analyses compared with conventional clinical microbiology data of septic patients. The anti-infective treatment regime and (fungal) SIQ scores for species identified via NGS of the respective plasma samples are reported for a time course of 28 days (indicated by the <span class="html-italic">x</span>-axis) for patients S16 (<b>A</b>), S25 (<b>B</b>), and S35 (<b>C</b>). Only species identified by SIQ-score analyses are indicated at the left side. Red colored boxes reveal ranking of highest SIQ scores for the respective species in every patient. Pertinent (clinical microbiology) laboratory results are marked using arrows to indicate the day the clinical specimen was obtained. (<b>A</b>) A 73-year old male patient presented with a tumor of his bile duct with the need for a palliative resection. The surgical procedure included resections of the bile duct as well as the gallbladder and was followed by a double bypass procedure (biliodigestive anastomosis and gastrojejunal anastomosis). Four days after the initial operation the patient suffered from septic shock due to a duodenal ulcer perforation with the need for a total pancreatectomy. Shortly after, the patient suffered from another small bowel leakage, so that an additional small bowel resection had to be performed. Blood cultures at sepsis onset were shown to be negative, and meropenem (MEM) was administered in terms of an empiric antibiotic therapy. However, the patient suffered from a therapy-refractory course of the disease and <span class="html-italic">C. albicans</span> could be isolated from abdominal drainage fluids 6 days after sepsis onset. Accordingly, an additional antifungal treatment with fluconazole (FLC) was initiated. Due to the development of candidemia at 14 days after sepsis onset, this antifungal treatment regime was secondarily escalated towards caspofungin (CFG). These findings were in good agreement with next generation sequencing (NGS) diagnostics in plasma, since the SIQ-score was positive for <span class="html-italic">C. albicans</span> at the same timepoint. Abbreviations: NGS, next generation sequencing; SIQ, sepsis indicating quantifier; MEM, meropenem; IPM:CIL, imipenem/cilastatin; FLC, fluconazole; DOR, doripenem; CFG, caspofungin; BC, blood culture; CVC, central venous catheter; TS, tracheal secretion; (<b>B</b>) A 65-year old male patient suffered from a Klatskin tumor with the need for a right-sided hemihepatectomy. Due to an abscess at the resection site, the patient suffered from septic shock with the need for an interventional drainage 22 days after the initial operation. The further course was complicated by the development of a right-sided pleural empyema as well as recurrent intra-abdominal abscesses, which were both treated with repeated placements of interventional drainages. Empiric antibiotic therapy at sepsis onset included imipenem/cilastatin (IMP:CIL) in terms of a monotherapy. Culture-based microbiological diagnostics revealed no bacterial growth, whereas <span class="html-italic">C. glabrata</span> could be detected in both fluids of already positioned drainages as well as fresh puncture materials respectively. Based on these microbiological findings, the patient was classified as infected, so that an administration of caspofungin was started at 14 days after sepsis onset. Blood cultures remained negative for fungi at all time points. Contrariwise, a next generation sequencing (NGS)-based diagnostic approach in plasma samples of septic patients was able to support the presence of an invasive fungal infection already at 7 days after sepsis onset, since the SIQ-score was shown to be positive for <span class="html-italic">C. glabrata</span> at this time point. Unfortunately, a further evaluation of the patient’s course of the disease beyond 14 days after sepsis onset was not possible, since the patient denied further participation in the study. Abbreviations: CFG, caspofungin; IMP:CIL, imipenem/cilastatin; na, not available; nd, not detectable; NGS, next generation sequencing; SIQ, sepsis indicating; (<b>C</b>) A 71-year-old female patient presented with a right pleural empyema caused by a liver abscess with the need for a video-assisted thoracoscopy (VATS). One day after VATS, the patient suffered from an acute abdomen with septic shock due to a perforation of the sigmoid colon, so that a removal of the sigmoid colon had to be performed. A second explorative laparotomy was necessary at 10 days after sepsis onset, due to a messy drainage fluid with a suspicion of another bowel leakage. However, during the revision surgery no clear focus could be found. Empiric anti-infective treatment consisted of imipenem/cilastatin (IMP:CIL) in combination with fluconazole (FLC), which was further supplemented by vancomycin (VAC) for 2 days in the early phase after sepsis onset. Anti-infective treatment was stepwise deescalated, so that the patient was free of any antibiotics or antimycotics at 12 days after sepsis onset. In the further course of the disease, the administration of caspofungin (CFG) was started at 20 days after sepsis onset, since the patient did not recover well and drainage fluids were shown to be positive for <span class="html-italic">Candida</span> spp. repeatedly starting from 3 days after sepsis onset. In parallel, next generation sequencing (NGS)-based diagnostics revealed a positive SIQ-score for <span class="html-italic">C. glabrata</span> also at 3 days after sepsis onset, whereas blood cultures were found to be negative for fungi throughout the whole observation period. The end of the 28 day-observation period was further characterized by an insufficiency of the stump by Hartmann as well as the development of severe pneumonia with the key bacteria Pseudomonas aeruginosa and Enterococcus faecalis, so that another antibiotic treatment phase with piperacillin/tazobactam as well as inhaled tobramycin was initiated. Abbreviations: BC, blood culture; BL, bronchoalveolar lavage; CFG, caspofungin; FLC, fluconazole; IMP:CIL, imipenem/cilastatin; n.a, not available; NGS, next generation sequencing; SIQ, sepsis indicating quantifier; TBC, inhaled tobramycine, TS, tracheal secretion; TZP, piperacilline/tazobactam; VAC, vancomycin.</p>
Full article ">Figure 2 Cont.
<p>Time course (fungal) SIQ analyses compared with conventional clinical microbiology data of septic patients. The anti-infective treatment regime and (fungal) SIQ scores for species identified via NGS of the respective plasma samples are reported for a time course of 28 days (indicated by the <span class="html-italic">x</span>-axis) for patients S16 (<b>A</b>), S25 (<b>B</b>), and S35 (<b>C</b>). Only species identified by SIQ-score analyses are indicated at the left side. Red colored boxes reveal ranking of highest SIQ scores for the respective species in every patient. Pertinent (clinical microbiology) laboratory results are marked using arrows to indicate the day the clinical specimen was obtained. (<b>A</b>) A 73-year old male patient presented with a tumor of his bile duct with the need for a palliative resection. The surgical procedure included resections of the bile duct as well as the gallbladder and was followed by a double bypass procedure (biliodigestive anastomosis and gastrojejunal anastomosis). Four days after the initial operation the patient suffered from septic shock due to a duodenal ulcer perforation with the need for a total pancreatectomy. Shortly after, the patient suffered from another small bowel leakage, so that an additional small bowel resection had to be performed. Blood cultures at sepsis onset were shown to be negative, and meropenem (MEM) was administered in terms of an empiric antibiotic therapy. However, the patient suffered from a therapy-refractory course of the disease and <span class="html-italic">C. albicans</span> could be isolated from abdominal drainage fluids 6 days after sepsis onset. Accordingly, an additional antifungal treatment with fluconazole (FLC) was initiated. Due to the development of candidemia at 14 days after sepsis onset, this antifungal treatment regime was secondarily escalated towards caspofungin (CFG). These findings were in good agreement with next generation sequencing (NGS) diagnostics in plasma, since the SIQ-score was positive for <span class="html-italic">C. albicans</span> at the same timepoint. Abbreviations: NGS, next generation sequencing; SIQ, sepsis indicating quantifier; MEM, meropenem; IPM:CIL, imipenem/cilastatin; FLC, fluconazole; DOR, doripenem; CFG, caspofungin; BC, blood culture; CVC, central venous catheter; TS, tracheal secretion; (<b>B</b>) A 65-year old male patient suffered from a Klatskin tumor with the need for a right-sided hemihepatectomy. Due to an abscess at the resection site, the patient suffered from septic shock with the need for an interventional drainage 22 days after the initial operation. The further course was complicated by the development of a right-sided pleural empyema as well as recurrent intra-abdominal abscesses, which were both treated with repeated placements of interventional drainages. Empiric antibiotic therapy at sepsis onset included imipenem/cilastatin (IMP:CIL) in terms of a monotherapy. Culture-based microbiological diagnostics revealed no bacterial growth, whereas <span class="html-italic">C. glabrata</span> could be detected in both fluids of already positioned drainages as well as fresh puncture materials respectively. Based on these microbiological findings, the patient was classified as infected, so that an administration of caspofungin was started at 14 days after sepsis onset. Blood cultures remained negative for fungi at all time points. Contrariwise, a next generation sequencing (NGS)-based diagnostic approach in plasma samples of septic patients was able to support the presence of an invasive fungal infection already at 7 days after sepsis onset, since the SIQ-score was shown to be positive for <span class="html-italic">C. glabrata</span> at this time point. Unfortunately, a further evaluation of the patient’s course of the disease beyond 14 days after sepsis onset was not possible, since the patient denied further participation in the study. Abbreviations: CFG, caspofungin; IMP:CIL, imipenem/cilastatin; na, not available; nd, not detectable; NGS, next generation sequencing; SIQ, sepsis indicating; (<b>C</b>) A 71-year-old female patient presented with a right pleural empyema caused by a liver abscess with the need for a video-assisted thoracoscopy (VATS). One day after VATS, the patient suffered from an acute abdomen with septic shock due to a perforation of the sigmoid colon, so that a removal of the sigmoid colon had to be performed. A second explorative laparotomy was necessary at 10 days after sepsis onset, due to a messy drainage fluid with a suspicion of another bowel leakage. However, during the revision surgery no clear focus could be found. Empiric anti-infective treatment consisted of imipenem/cilastatin (IMP:CIL) in combination with fluconazole (FLC), which was further supplemented by vancomycin (VAC) for 2 days in the early phase after sepsis onset. Anti-infective treatment was stepwise deescalated, so that the patient was free of any antibiotics or antimycotics at 12 days after sepsis onset. In the further course of the disease, the administration of caspofungin (CFG) was started at 20 days after sepsis onset, since the patient did not recover well and drainage fluids were shown to be positive for <span class="html-italic">Candida</span> spp. repeatedly starting from 3 days after sepsis onset. In parallel, next generation sequencing (NGS)-based diagnostics revealed a positive SIQ-score for <span class="html-italic">C. glabrata</span> also at 3 days after sepsis onset, whereas blood cultures were found to be negative for fungi throughout the whole observation period. The end of the 28 day-observation period was further characterized by an insufficiency of the stump by Hartmann as well as the development of severe pneumonia with the key bacteria Pseudomonas aeruginosa and Enterococcus faecalis, so that another antibiotic treatment phase with piperacillin/tazobactam as well as inhaled tobramycin was initiated. Abbreviations: BC, blood culture; BL, bronchoalveolar lavage; CFG, caspofungin; FLC, fluconazole; IMP:CIL, imipenem/cilastatin; n.a, not available; NGS, next generation sequencing; SIQ, sepsis indicating quantifier; TBC, inhaled tobramycine, TS, tracheal secretion; TZP, piperacilline/tazobactam; VAC, vancomycin.</p>
Full article ">Figure 3
<p>Plasma concentrations of β-<span class="html-small-caps">d</span>-glucan (BG) in patients with septic shock. Plasma concentrations of BG were measured in patients suffering from septic shock with a fungal infection (grey squared box), a fungal colonization (grey plane box) or without any fungal findings (white box). Plasma samples were collected at the onset of septic shock (T0), and 1 day (T1), 2 days (T2), 7 days (T3), 14 days (T4), 21 days (T5), and 28 days (T6) afterwards. Data in box plots are given as median, 25th percentile, 75th percentile with the 10th as well as 90th percentile at the end of the whiskers.</p>
Full article ">Figure 4
<p>Plasma concentrations of interleukin (IL)-17A in patients with septic shock. Legend: (<b>A</b>) Plasma concentrations of IL-17A were measured in patients suffering from septic shock with a fungal infection (grey squared box), a fungal colonization (grey plane box) or without any fungal findings (white box). Plasma samples were collected at the onset of septic shock (T0), and 1 day (T1), 2 days (T2), 7 days (T3), 14 days (T4), 21 days (T5), and 28 days (T6) afterwards. Data in box plots are given as median, 25th percentile, 75th percentile with the 10th as well as 90th percentile at the end of the whiskers. Concerning symbolism and higher orders of significance: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01, *** <span class="html-italic">p</span> &lt; 0.001; (<b>B</b>) Receiver operating characteristic (ROC) analysis with IL-17A in all participating patients at sepsis onset (T0), and 1 day (T1), 2 days (T2) as well as 7 days (T3) afterwards with regard to the prediction of a fungal infection up to day 28. Patients suffering from a fungal infection represented the target group, whereas both, patients with a fungal colonization as well as patients without any fungal isolates served as controls for this ROC-analysis.</p>
Full article ">Figure 5
<p>Plasma concentrations of mid-regional proadrenomedullin (MR-proADM) in patients with septic shock. Legend: (<b>A</b>) Plasma concentrations of MR-proADM were measured in patients suffering from septic shock with a fungal infection (grey squared box), a fungal colonization (grey plane box) or without any fungal findings (white box). Plasma samples were collected at the onset of septic shock (T0), and 1 day (T1), 2 days (T2), 7 days (T3), 14 days (T4), 21 days (T5), and 28 days (T6) afterwards. Data in box plots are given as median, 25th percentile, 75th percentile with the 10th as well as 90th percentile at the end of the whiskers. Concerning symbolism and higher orders of significance: * <span class="html-italic">p</span> &lt; 0.05, ** <span class="html-italic">p</span> &lt; 0.01; (<b>B</b>) Receiver operating characteristic (ROC) analysis with MR-proADM in all participating patients at sepsis onset (T0), and 1 day (T1), 2 days (T2) as well as 7 days (T3) afterwards with regard to the prediction of a fungal infection up to day 28. Patients suffering from a fungal infection represented the target group, whereas both, patients with a fungal colonization as well as patients without any fungal isolates, served as controls for this ROC-analysis.</p>
Full article ">Figure 6
<p>Early transcriptional host response of vulvovaginal RHE. Legend: (<b>A</b>) Hierarchical clustering of the set of 21 differentially expressed genes based on their fold changes. For each infected condition the uninfected control at the corresponding timepoint dealt as reference condition; (<b>B</b>) Expression values of late-stage <span class="html-italic">Candida</span>-induced cytokines compared to ADM.</p>
Full article ">
1662 KiB  
Article
Rho-Kinase Blockade Attenuates Podocyte Apoptosis by Inhibiting the Notch Signaling Pathway in Diabetic Nephropathy
by Keiichiro Matoba, Daiji Kawanami, Yosuke Nagai, Yusuke Takeda, Tomoyo Akamine, Sho Ishizawa, Yasushi Kanazawa, Tamotsu Yokota and Kazunori Utsunomiya
Int. J. Mol. Sci. 2017, 18(8), 1795; https://doi.org/10.3390/ijms18081795 - 18 Aug 2017
Cited by 36 | Viewed by 6078
Abstract
Podocyte apoptosis is a key process in the onset of diabetic nephropathy. A significant body of evidence shows that the Notch signaling pathway plays a central role in this process. We found that Rho-kinase mediates transforming growth factor β (TGF-β)-induced Notch ligand Jag1 [...] Read more.
Podocyte apoptosis is a key process in the onset of diabetic nephropathy. A significant body of evidence shows that the Notch signaling pathway plays a central role in this process. We found that Rho-kinase mediates transforming growth factor β (TGF-β)-induced Notch ligand Jag1 expression. Importantly, TGF-β-mediated podocyte apoptosis was attenuated by Rho-kinase inhibition. Mechanistically, Rho-kinase regulated Jag1 induction via the extracellular signal-regulated kinase (ERK) 1/2 and c-Jun N-terminal kinase (JNK) but not Smad pathways. Consistently, the Rho-kinase inhibitor fasudil prevented albuminuria and the urinary excretion of nephrin in db/db mice and reduced the prevalence of podocyte apoptosis and Jag1 expression. Finally, the expression of Jag1 and apoptosis markers such as Bax and cyclin-dependent kinase inhibitor 1A (CDKN1A) was decreased in podocytes derived from db/db mice treated with fasudil. The present study provides evidence that Rho-kinase plays a key role in podocyte apoptosis. Rho-kinase is an attractive therapeutic target for diabetic nephropathy. Full article
(This article belongs to the Special Issue Advances in Chronic Kidney Disease 2017)
Show Figures

Graphical abstract

Graphical abstract
Full article ">Figure 1
<p>Rho-Kinase mediates transforming growth factor β (TGF-β)-induced Jag1 expression in podocytes. Differentiated E11 podocytes were stimulated with TGF-β (5 ng/mL) for the indicated durations (<b>A,B</b>). (<b>A</b>) RNA was extracted, and Jag1 mRNA was analyzed by real-time quantitative PCR, with GAPDH mRNA as the internal standard; (<b>B</b>) The amount of Jag1 protein in cell lysates from podocytes was determined by Western blotting; (<b>C</b>) Cell lysates were collected from E11 podocytes stimulated with TGF-β (5 ng/mL) for 1 min. RhoA activity was determined by G-LISA RhoA assay; (<b>D</b>) Podocytes were pretreated with Y-27632 (10 µM) and then stimulated with TGF-β (5 ng/mL) for 1 h. Rho-kinase activity was measured as described in the Materials and methods section; (<b>E</b>) E11 podocytes were pretreated with Y-27632 (10 µM) before stimulation with TGF-β (5 ng/mL) for 8 h. Jag1 mRNA was analyzed by real-time quantitative PCR; (<b>F</b>) Podocytes were stimulated by TGF-β for 24 h after treatment with Y-27632. The protein expression of Jag1 was analyzed by Western blotting. A representative blot of three independent experiments is shown; (<b>G</b>) Podocytes stimulated with TGF-β (8 h) were treated with scramble control siRNA or Rho-kinase isoform specific siRNA and analyzed by real-time quantitative PCR. * <span class="html-italic">p</span> &lt; 0.05 vs. control siRNA with TGF-β. The data are presented as means ± SD.</p>
Full article ">Figure 2
<p>Rho-Kinase mediates podocyte apoptosis. (<b>A</b>) Representative photomicrographs and quantification of condensed nuclei in podocytes. E11 podocytes were pretreated with Y-27632 (10 µM) and then stimulated with TGF-β (5 ng/mL) for 24 h; (<b>B</b>) Microphotographs and quantification of TUNEL-positive apoptotic podocytes. Original magnification, ×400. * <span class="html-italic">p</span> &lt; 0.05. The data are presented as means ± SD.</p>
Full article ">Figure 3
<p>Mitogen-activated protein kinases (MAPKs) are signaling intermediates required for Rho-kinase-mediated Jag1 induction. (<b>A</b>) Differentiated E11 podocytes were pretreated with Smad3 inhibitor (SIS3, 10 µM) and then stimulated with TGF-β (5 ng/mL) for 8 h. Jag1 mRNA was analyzed by real-time quantitative PCR; (<b>B</b>) Podocytes were pretreated with Y-27632 (10 µM) before stimulation with TGF-β (5 ng/mL) for 30 min. Cell lysates were subjected to Western blotting. A representative blot of three independent experiments is shown; (<b>C</b>) Podocytes were stimulated with TGF-β for 8 h with or without pretreatment of MAPK inhibitors (50 µM). RNA was extracted, and Jag1 mRNA was analyzed by real-time quantitative PCR, with GAPDH mRNA as the internal standard. * <span class="html-italic">p</span> &lt; 0.05 vs. DMSO with TGF-β; (<b>D</b>) Podocytes were pretreated with Y-27632 (10 µM) and then stimulated with TGF-β (5 ng/mL) for 30 min. Equal amounts of cell lysate were subjected to Western blotting using MAPKs antibodies. A representative blot of three independent experiments is shown. The data are presented as means ± SD.</p>
Full article ">Figure 4
<p>Treatment of <span class="html-italic">db</span>/<span class="html-italic">db</span> mice with fasudil prevents podocyte loss. (<b>A</b>) A representative blot of three independent experiments and quantitative analyses of the phosphorylated form of myosin phosphatase target subunit 1 (MYPT1) (p-MYPT1) and MYPT1 in protein extracts from the renal cortex of <span class="html-italic">db</span>/<span class="html-italic">m</span> mice, <span class="html-italic">db</span>/<span class="html-italic">m</span> mice given fasudil (<span class="html-italic">db</span>/<span class="html-italic">m</span> + fasudil), <span class="html-italic">db</span>/<span class="html-italic">db</span> mice, and fasudil-treated <span class="html-italic">db</span>/<span class="html-italic">db</span> mice (<span class="html-italic">db</span>/<span class="html-italic">db</span> + fasudil); (<b>B</b>) Representative photomicrographs of periodic acid-Schiff (PAS) and WT1-stained kidney sections. Original magnification, ×400; Quantitative analyses of WT1-positive cells in (<b>C</b>) the glomerulus and the urinary excretion of nephrin; (<b>D</b>–<b>F</b>) TUNEL-stained glomerular cells and changes in the albumin excretion in each group; (<b>G</b>) Jag1 and apoptotic markers were analyzed in the isolated podocytes. * <span class="html-italic">p</span> &lt; 0.05. The data are presented as the means ± SD. (<span class="html-italic">n</span> = 5 in each group).</p>
Full article ">Figure 4 Cont.
<p>Treatment of <span class="html-italic">db</span>/<span class="html-italic">db</span> mice with fasudil prevents podocyte loss. (<b>A</b>) A representative blot of three independent experiments and quantitative analyses of the phosphorylated form of myosin phosphatase target subunit 1 (MYPT1) (p-MYPT1) and MYPT1 in protein extracts from the renal cortex of <span class="html-italic">db</span>/<span class="html-italic">m</span> mice, <span class="html-italic">db</span>/<span class="html-italic">m</span> mice given fasudil (<span class="html-italic">db</span>/<span class="html-italic">m</span> + fasudil), <span class="html-italic">db</span>/<span class="html-italic">db</span> mice, and fasudil-treated <span class="html-italic">db</span>/<span class="html-italic">db</span> mice (<span class="html-italic">db</span>/<span class="html-italic">db</span> + fasudil); (<b>B</b>) Representative photomicrographs of periodic acid-Schiff (PAS) and WT1-stained kidney sections. Original magnification, ×400; Quantitative analyses of WT1-positive cells in (<b>C</b>) the glomerulus and the urinary excretion of nephrin; (<b>D</b>–<b>F</b>) TUNEL-stained glomerular cells and changes in the albumin excretion in each group; (<b>G</b>) Jag1 and apoptotic markers were analyzed in the isolated podocytes. * <span class="html-italic">p</span> &lt; 0.05. The data are presented as the means ± SD. (<span class="html-italic">n</span> = 5 in each group).</p>
Full article ">
Previous Issue
Back to TopTop